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Summery 
Aspergillus is a genus of filamentous fungi, which members includes industrial producers of 
enzymes, organic acids and secondary metabolites, important pathogens and a model organism. As 
such no matter the specific area of interest there are many reasons to perform genetic engineering, 
whether it is metabolic engineering to create better performing cell factory, elucidating pathways to 
study secondary metabolism etc. In this thesis, the main focus is on different ways to manipulate 
DNA repair for optimizing gene targeting, ultimately improving the methods available for faster 
and better genetic engineering strategies. 
Chapter 1 gives an introduction to the genus Aspergillus and some of the tools relevant to fungal 
genetic engineering. It also contains a short introduction to DNA repair and its interplay with gene 
targeting and finally an overview over the different genome editing technologies, providing a 
background for the other chapters. 
Aspergillus nidulans is a model organism, with a range of genetic tools developed, and therefore the 
approach in this thesis has been to use it for proof of concept, and once a method has been 
established in A. nidulans it can be transferred to other Aspergilli.  
In chapter 2, the focus is on a concept for allowing simultaneous, but transient disruptions of genes 
of interest, with the main goal being creating a strain with transient disruptions of both pyrG and 
nkuA. This would yield a strain with a robust selection marker and high rates of gene targeting. 
However, since the same trait, while beneficial for genetic engineering, is a detriment during a 
fermentation process where a robust DNA repair system and a prototrophic background are 
important traits. By inserting a marker gene into an intron, flanked by loxP sites, its presence will 
interfere with intron splicing, however it can be excised by the cre recombinase, leaving only a 
single loxP scar in the intron, which if placed correctly will not interfere with intron-splicing and 
restore function. This was demonstrated to work in two different introns in the pigment gene yA in 
A. nidulans as a proof of concept, and the concept was expanded to include the tetON promoter 
controlling the cre recombinase gene as part of the insert and also testing whether it is tolerated to 
insert or replace an intron from one gene to another, which were partial successful. Finally, a 
transient pyrG mutation was introduced in a marker free strain of A. nidulans, and successfully 
tested and similarly a disruption of nkuA was made. 
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Genome editing is not a new concept, but never has it been as accessible as it is now due to the 
CRISPR-Cas9 technology. In chapter 3, a versatile CRISPR-Cas9 system for use in various 
Aspergillus species was made, consisting of four vectors each with a different selection marker. To 
successfully express the two components of CRISPR-Cas9, Cas9 was codon-optimized to A. niger, 
and a ribozyme based strategy was used for gRNA expression. With a functional system in place, I 
demonstrated how it could be used to disable genes by mutagenesis, but also how it could be used 
to greatly enhance gene targeting frequencies in wild type strains, similar to what is observed when 
using non-homologous end-joining (NHEJ) deficient strains. Furthermore, a perl script for 
identifying protospacers in common for gene homologs across multiple species was developed. 
While the initial experiments were made in A. nidulans and A. aculeatus, this was used to quickly 
demonstrate that the system could be used in more species, and mutagenesis was done in four 
additional species. 
In chapter 4 the focus stays on CRISPR-Cas9, focusing on three aspects. Alternative methods for 
gRNA expression, strategies for limiting off-targeting effects, and how to combine CRISPR-Cas9 
with the traditional strategy of disabling NHEJ for even greater results. Four other promoters were 
tested for their ability to express functional gRNA, chosen based on which has been shown to work 
in other species. However, none of them worked in A. nidulans and the ribozyme based strategy 
remained the most effective. Next two strategies for limiting potential off-targeting effects using 
CRISPR-Cas9 were explored. One was based on using a shorter protospacer than the 20 bp that is 
normally used. 17 bases of length was tested in A. nidulans, but lead to aberrant sporeless colonies. 
The other strategy was based on inactivating one of the cleavage domains in the Cas9 protein, 
turning it into a nickase and then use two gRNAs to create two nicks in close proximity on opposite 
strands rather than a single double-strand break. Results indicated that it could be a viable strategy 
to stimulate gene targeting while lowering potential off-targeting. Finally I demonstrated by 
combining CRISPR-Cas9 with an NHEJ deficient background, it was possible to do gene targeting 
without selection for DNA to be integrated and furthermore that, for small changes, such as for 
introducing point mutations, it was possible to use short single-stranded oligos. 
Overall several very useful tools for genetic engineering of various Aspergillus species were 
developed as a part of this thesis, and especially the CRISPR-Cas9 based tools have the potential to 
transform genetic engineering strategies. 
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Sammenfatning 
Aspergillus er en slægt filamentøse svampe, som inkluderer flere industrielt relevante arter, som er i 
stand til at producere enzymer, organiske syrer og sekundære metabolitter, men også arter som er 
vigtige patogener eller model organismer. Derfor, uanset det specifikke interesseområde, er der 
mange årsager til, hvorfor det kan være relevant at genmanipulere disse organismer, hvilket 
inkluderer at lave cellefabriker, undersøge specifikke synteseveje, studere sekundær metabolisme 
el.lign. Denne afhandling er centreret omkring forskellige måder, DNA reparations mekanismerne 
kan blive udnyttet til at optimere introduktion af specifikke mutationer og generelt forbedre 
strategier for at genmanipulere Aspergillus arter. 
Kapitel 1 er en introduktion til Aspergillus slægten og mange af de relevante redskaber der er til 
genmanipulation af disse skimmelsvampe. Derudover er der også en kortfattet introduktion til DNA 
reparation og dets relevans for genmanipulation. Endelig er der en kort oversigt over nogle af de 
forskellige gen editerings teknologier som eksisterer, hvilket er relevant for de senere kapitler.  
Aspergillus nidulans er model organisme, for hvilken adskillige genetiske redskaber er blevet 
udviklet. Derfor har udgangspunktet i denne afhandling været at A. nidulans har været anvendt til at 
teste koncepter, hvorefter de bliver overført til andre Aspergillus arter. 
I kapitel 2, var målet en metode for at lave reversible gen afbrydelser, hvoraf hovedformålet var at 
lave en stamme midlertidigt afbrudt i både pyrG og nkuA i A. nidulans. Dette vil resultere i en 
stamme som har en mod-selekterbar genetisk selektions markør, men som også inkorporerer 
heterolog DNA ved hjælp homolog rekombination, hvilke tillader at lave præcise ændringer i 
svampens genom. De samme to træk er dog en ulempe i fermenterings processer, hvor en god 
produktionsstamme gerne skal være prototrof og med et robust DNA reparations system. Ideen er at 
indsætte en dominant markør flankeret af loxP sites ind i intronen af det gen som skal afbryde. Så 
længe det er indsat i intronen vil dets tilstedeværelse forhindre intron splejsning, i praksis forhindre 
translation. Til gengæld med cre rekombinasen er det muligt at skære det indsatte DNA ud igen og 
kun efterlade et enkelt loxP site, hvilket, hvis det er placeret korrekt, ikke interfererer med intron 
splejsning. Først blev konceptet testet ved succesfuldt at afbryde og restaurere pigment genet yA. 
Derefter blev konceptet udvidet til at inkludere cre rekombination genet under kontrol af tetON 
promoter, og derudover blev det testet om det muligt at indsætte eller udskifte en intron fra et gen til 
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et andet, hvilket var delvist succesfuldt. Til sidst blev pyrG succesfuldt midlertidigt afbrudt i en 
markørfri stamme, og en tilsvarende mutation blev indført i nkuA genet. 
Genom editerings teknologi er ikke et nyt koncept, men det har aldrig været så tilgængeligt som det 
er nu. I kapitel 3 blev et fleksibelt CRISPR-Cas9 system udviklet, bestående af fire vektorer med 
forskellige selektions markører, hvilket kan blive anvendt i forskellige arter. CRISPR-Cas9 kræver 
to komponenter for at virke. Cas9 var kodon optimeret til at matche A. niger, mens en strategi 
baseret på ribozymes blev anvendt til at udtrykke gRNA’et. Med et funktionelt system, var det 
muligt at afbryde gener ved mutagenese, men også booste frekvensen hvorved heterolog DNA 
bliver integreret ved homolog rekombination, tilsvarende den effekt som ses når man fjerner 
svampens evne til at reparere DNA dobbelt strengs brud ved hjælp af illegitim rekombination. 
Derudover blev et Perl script udviklet til at kunne identificere protospacers som fungerer i flere 
homologer af det samme gen i forskellige arter. Som udgangspunkt blev CRISPR-Cas9 testet i to 
arter, A. nidulans and A. aculeatus, men scriptet blev udnyttet til at demonstrere at systemet var 
funktionelt i yderligere fire arter. 
Kapitel 4 fokuserer på tre forskellige aspekter af anvendelsen af CRISPR-Cas9. Først blev 
alternative promotere testet for deres evne til succesfuldt at udtrykke gRNA’er. Disse var valgt, 
baseret på hvad der har virket i andre organismer. Desværre virkede ingen af dem ud over den 
ribozyme baserede strategi præsenteret i kapitel 3. Derefter blev to forskellige strategier som kan 
begrænse potentielle problemer med ”off-targeting” testet. Den første var baseret på at anvende 
protospacere som var 17 baser lange i stedet for 20, men det gav sære sporeløse kolonier og var 
ikke en succes. Derimod virkede strategien med at omdanne Cas9 til en nickase og anvende to 
gRNA’er til at lave to nicks i stedet for et enkelt dobbelt strengs brud, til at stimulere integration 
ved hjælp af homolog rekombination. Endelig viste jeg at man ved at kombinere CRISPR-Cas9 
med at afbryde illegitim rekombination, er det muligt at lave gen modificationer uden at efterlade en 
selektion markør i genomet. Derudover demonstrerede jeg at det er muligt at bruge enkelt strengede 
oligoer i stedet for konventionelle vektorer når der skal introduceres små modifikationer. 
Alt i alt har denne afhandling resulteret i adskillige brugbare værktøjer til at lave genetiske 
modifikationer og især de CRISPR-Cas9 baserede redskaber har potentiale til at ændre 
konventionelle strategier for genmanipulation i Aspergillus arter. 
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Chapter 1: Introduction 
Industrial fungal biotechnology 
The fungal kingdom comprises of a wide range of very diverse organism. Members includes yeasts, 
such as Saccharomyces cerevisiae, mushrooms and filamentous fungi. In nature fungi are important 
degraders of biomass [1], able to grow in a wide range of environments. 
Aspergillus is a genus of filamentous fungal species, containing a lot of scientifically, medically or 
industrial important species [2]. Aspergillus nidulans was early proposed as a model organism for 
genetics [3] and later also used for studies of the cell cycle and mitosis in eukaryotes [4]. 
Aspergillus oryzae has a much longer history of human use, being used for a wide range of Asian 
fermented products such as soy sauce, miso and sake for more than 2000 year [5], but is also used 
in modern biotechnology for the production of enzymes, and is considered an industrially relevant 
fungus. Aspergillus niger is likewise used in modern biotech, both for the production of enzymes, 
but also for production of organic acids, such as citric acid. Together with Aspergillus fumigatus, an 
important fungal pathogen, infecting immunocompromised patients [6], these four aspergilli were 
the first to be genome sequenced, though the A. niger genome was released later [7–10], and 
although many others have joined since then, and currently approximately 300 Aspergilli are being 
or stated to be sequenced, as a part of the Aspergillus Whole-genus sequencing project 
(http://genome.jgi.doe.gov/). While A. niger and A. oryzae are the two big industrial Aspergilli, and both 
of them have obtained GRAS status from the FDA, many of the traits that makes them excellent 
production organisms, can also be found in other Aspergilli. Due to the saprophytic lifestyle, 
Aspergilli in general have a strong secretion apparatus, and are able to secrete the enzymes 
necessary for degrading of biomass. Besides the potential of secretion of proteins and organic acids, 
Aspergilli also presents a huge reservoir of interesting secondary metabolites. For instance 
Aspergillus terreus is a natural producer of lovastatin, an important cholesterol lowering agent. The 
secondary metabolites of some species also present huge problems.  For instance Aspergillus flavus 
being a food spoilage agent, but also producer of the extremely carcinogenic compound aflatoxin. 
There are therefore many compelling reasons for studying the various Aspergilli in detail, also at a 
molecular level, both for basic research purposes and for the improvement of industrial strains. 
With more and more sequences becoming available for study, the pressure is on the molecular tools 
for genetic engineering to keep up. 
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Tools for genetic engineering of filamentous fungi 
The first report on a transformation in a filamentous fungi, was on Neuraspora crassa [11], while a 
report on using Aspergillus nidulans followed in 1983 [12]. The fungal cell wall provided a 
challenge, unlike when transforming prokaryotes. This was however overcome by protoplastation, 
in which the cell wall is enzymatically degraded. Other methods for transformation includes 
electroporation [13], biolistic transformation [14] and Agrobacterium-mediated transformation [15]. 
Once the DNA is introduced, there  are essentially two ways for it to be propagated, either by 
integration into the genome or by autonomously replication, such as by the AMA1 element [16]. 
While the AMA1 element can be used for transient expression, it is mitotically unstable, being 
readily lost over time [16], and in order to be used for stable expression, genomic integration is 
necessary. The manner in which DNA can integrate into the genome depends on several factors and 
will be discussed in the next section.  
Another factor that is crucial for transformation is the availability of selection markers, in order to 
separate cells which have taken up the DNA in question from those who have not. Selection 
markers can generally be divided into nutritional and antibiotic markers. Various antifungal drugs 
have successfully been used as selection markers in various Aspergilli, including hygromycin 
[17,18], bleomycin [19], and oligomycin [20]. Nutritional markers include auxotrophic markers 
which are created by disabling a gene in a pathway responsible for the synthesis of an essential 
compound. Commonly used markers includes pyrG, encoding an orotidine-5´-phosphate 
decarboxylase, which if disabled causes uridine auxotrophy [21] and argB encoding an ornithine 
carbamoyltransferase which if disabled causes arginine auxotrophy, but many other nutritionally 
important genes can similarly be used. Many of these being responsible for the synthesis of various 
amino acids or vitamins. Of special interest is that while some nutritional genes behave as a 
classical auxotrophic marker gene in their native host, requiring a null-mutant before it can be 
utilized as selection marker, others can also be used as a dominant nutritional selection marker in 
other species. One example of this type of marker gene is the A. nidulans amdS gene, which if 
disrupted or deleted prevents the utilization of acetamide as nitrogen source [22]. Wildtype A. niger 
however grows poorly with acetamide as nitrogen source, and as such amdS can be used a dominant 
nutritional selection marker [23]. In addition some selection markers, including pyrG and amdS 
have the advantage that not only is it possible to select for their presence but also their absence. The 
pyrG marker can be counter-selected by 5-fluoroorotic acid (5-FOA), while amdS can be counter-
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selected by 5’-fluoroacetamide (FAA). This allows these marker genes, if flanked with repetitive 
DNA sequences, to be reused since the marker genes then can be recycled by direct repeat 
recombination. 
Another important consideration, especially for expression of heterologous proteins, but also as a 
tool for changing regulation of native genes, is the choice of promoter since it affects both the 
regulation and expression levels of the gene it controls. Promoters are in general divided into 
constitutive and inducible promoters. While constitutively expressed genes are active independent 
on growth conditions, genes expressed from inducible promoters can potentially allow for fine-
tuning of the fermentation process by controlling when the protein or metabolite production starts. 
Some of the first inducible promoters used includes the A. nidulans alcA promoter [24] from the 
alcohol dehydrogenase I, and the glucoamylase, glaA of A. niger. The alcA promoter is induced by 
the presence of acetaldehyde, while the glaA promoter is induced when maltose or starch is the sole 
carbon source [25]. A drawback is that both of these promoters are repressed by glucose which 
limits their application. In general the considerations for choosing an inducible promoter includes 
both the strength of the promoter when induced, the tightness of the promoter when not induced, the 
suitability of inducers and repressor to the fermentation process and the potential cost of inducers. 
Besides alcA and glaA there are many other Aspergillus promoters, responding to different 
environmental condition or inducers, which have successfully been used for various production 
strategies [2,25]. An alternative to using native Aspergillus promoters, is adapting inducible 
promoter systems from other organisms, which often depends on different types of inducers, and is 
de-coupled from the metabolism of the cell, such as the prokaryotic tetON promoter, responding to 
tetracycline and doxycycline [26,27]. 
Alternative to using inducible promoters, is constitutive promoters which are not dependent 
inducers or tied to the growth condition. Classical examples of those includes the A. nidulans gpdA 
promoter, from the Glyceraldehyde-3-phosphate dehydrogenase gene [28], the A. oryzae tef1 
promoter, from the translation-elongation factor gene [29] and the A. nidulans oliC promoter, from 
a mitochondrial ATP synthase subunit gene. Interestingly most of these promoters originating from 
one Aspergilli, functions across many of the different Aspergilli species. 
While also impacting transcription, often much less consideration is given to the choice of 
terminator [2]. However the terminator affects the stability of the transcript and thus the half-life of 
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the RNA [30], and as such it can have significant effect on protein production. For instance in the 
yeast, S. cerevisiae exchanging the commonly used CYC1 terminator for a synthetic one, increased 
production of yellow fluorescent protein by 3.7 fold, while the promoter was the same [31].  
Another very important factor greatly affecting gene expression is where and in how many copies a 
gene is located. When DNA is integrated into the genome it can happen by three possible DNA 
repair pathways, as described in the next session, however it comes down to where the DNA goes in 
at a defined location by homologous recombination (HR) or to a random or potential several 
random locations by non-homologous end-joining (NHEJ). Due to its relatively late recognition as 
an independent DNA repair pathway, to which degree events classified NHEJ events are actually a 
results of micro-homology end-joining (MMEJ) is unknown. The location where the DNA is 
integrated has a huge impact on gene expression. Some locations support high levels of gene 
expression, while for instance chromatin structure, in the form of hetero chromatin and telomeric 
silencing effects can negatively impact transcription [32]. Another aspect to consider besides the 
impact of the location of the gene in question, is the effect on the neighboring genes. A common 
strategy to circumvent these issues is by the definition of integration sites, where typically identical 
constructs for expression of an easily quantifiable protein is tested in different location, combined 
with test of either growth rate or expression of neighbor genes [33–35]. Of course to take advantage 
of such predefined sites, it requires that the location of the insert can be controlled, which requires 
integration by HR. Also other sorts of modifications, focusing on the existing genes, such as gene 
deletions and point mutations are fully dependent on integration by HR. However, from the 
perspective of insertion of genes, random integration is still interesting since it comes with both 
advantages and disadvantages. Random integration of DNA poses the risk of disrupting native 
genes or hitting locations detrimental for gene expression, but there is also the possibility of 
multiple inserts. Data from A. oryzae, A. niger and Trichoderma reesei suggest that up to 
approximately five copies there is linear correlation between copy numbers of an insert and 
resulting protein production, while dose/response relation is lacking at higher copy numbers [36]. 
One reason for the limited effects of multiple copies, in the case of inducible promoters such as 
alcA and glaA promoters are limited availability of the regulation proteins [2,25,36]. Another 
concern is a tendency of multiple inserts to integrate in tandem, resulting in genomic instability due 
to the risk of direct repeat recombination. 
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DNA repair 
Genetic engineering is a wide concept, which roughly can be defined as techniques that allow for 
editing of the genome of an organism and includes introduction of new genes, either targeted or 
randomly inserted, deletion or disruption of existing genes and the introduction or repair of point 
mutations. 
The ability to do targeted genetic manipulations is intrinsically linked to DNA repair in the cell. 
Eukaryotes have traditionally been considered to have two major repair pathways, non-homologous 
end-joining (NHEJ) and homologous recombination (HR), while more recent microhomology-
mediated end-joining (MMEJ) have begun to be considered as a third major repair pathway [37], 
rather than a backup system to NHEJ. The choice between these three pathways has major impact 
on how amenable an organism is to genetic engineering, and depends both on the organism itself, 
but also in which stage of the cell cycle it is in. The three pathways are illustrated in Figure 1.1. 
Relatively little research have been done on DNA repair in Aspergillus, and therefore, unless 
specifically stated the following sections are based on information from the yeast S. cerevisiae or 
mammalian systems, since significantly more research into DNA repair are being done in these 
organisms. Furthermore, while there are many types of DNA damage and also many ways to repair 
it, this section will focus on double strand break repair, since those breaks are the interesting ones 
concerning gene targeting and genome editing technologies. 
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Figure 1.1 Overview of the three major DNA repair pathways. A) Independent of pathway choice, repair is initiated by 
the recruitment of the MRX complex, bridging the broken ends. B) NHEJ is initiated by the recruitment of the Ku70-
Ku80 hetero dimer, protecting the broken ends. The Lig4 complex is then recruited to the site and the ends are ligated 
together. C) HR by contrast is initiated by resection, creating 3’ overhangs. RPA is recruited to the ssDNA, and then it is 
displaced by Rad51, assisted by Rad52. Rad51 forms a filament assisted by Rad55 and Rad57, which can then perform 
strand invasion. D) MMEJ is similar to HR initiated by resection. The resection reveals microhomologies which can 
anneal to each other, resulting in a deletion the intervening sequence. 
Non-homologous end-joining 
NHEJ is initiated by the recruitment of the Ku70 and Ku80 proteins, which forms a heterodimer, 
which binds to the DNA ends, protecting them from further damage and assists in recruiting the 
proteins necessary for downstream activity [37]. The names refers to the size of the human variants 
of the proteins, with Ku70 being ≈ 70 k dalton (kDA) and likewise the Ku80 being ≈ 80 kDa. The 
NHEJ pathway was first discovered in eukaryotes, where the Ku proteins, while displaying 
significant differences in sequences, are functionally conserved, to the degree where the human or 
Drosophila Ku70 can complement Ku70 null mutants in yeast [38]. Many bacteria however, also 
possess an NHEJ repair pathway [39], but the bacterial Ku proteins generally have one domain less 
than their eukaryotic counterparts [40]. As mentioned above the Ku hetero dimer covers the ends, 
which helps recruitment of the next proteins in the NHEJ pathway, however the Ku proteins also 
have other roles besides DNA repair by NHEJ. In yeast they have been shown to be involved in 
telomere maintenance [41], which has shown to be the same also in many other eukaryotes [42].  
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Besides the Ku hetero dimer, two other protein complexes are required for repair by NHEJ. In yeast 
the MRX complex, consisting of  Mre11, Rad50 and Xrs2, which unlike Ku also are involved in 
repair by HR [43]. Ku and MRX are recruited independently from each other, however it have been 
observed that in the absence of Ku MRX binds later [43]. MRX has several functions in DNA 
repair. It functions both as sensor of DSB, bridges the ends together, is involved in 5’-3’ end 
resection and also plays a role in telomeric maintenance [37]. After MRX and the Ku hetero dimer 
have bound to the DNA strands the lig4 complex, consisting of lig4, lif1 and nej1 is recruited [37]. 
Interestingly while recruitment of the lig4 complex is dependent on the Ku hetero dimer, later 
dissociation is dependent on MRX [43]. The lig4 complex is responsible for ligating the ends 
together, often without any mutations introduced. 
One important difference between NHEJ in yeast and in vertebrates, is that in vertebrates the Ku 
heterodimer is part of a DNA dependent protein kinase, with a catalytic subunit (DNA-PKcs), 
which is required for NEHJ [44]. Yeast however does not have a DNA-PKcs [44]. This means at 
least in S. cerevisiae that NHEJ is dependent on ends being compatible [37]. 
 Homologous recombination  
On a principal level, what distinguishes homologous recombination from the other two repair 
pathways is that instead of ligating available DNA ends together, it relies on a homologous donor 
sequence which is used a template for repair. Overall HR happens in three stages, resection, 
followed by strand invasion and then resolution of the recombination intermediate [45].  
Limited resection is initiated by the MRX complex together with an endonuclease Sae2, which 
together can remove oligonucleotides from the 5’ strand [37]. The MRX complex then assists 
recruiting of Exo1, Dna2 and a complex of Sgs1, Top3 and Rmi1, which all are involved in a more 
extensive resection [37].  
Resection exposes long single-stranded (ss) DNA overhangs which is required for homology search 
and  which is then covered by Replication Protein A (RPA) [45]. Next RPA interacts with Rad52 
which are involved in displacing RPA and recruiting Rad51 to the site instead [46]. Rad51 forms a 
filament, which is stabilized by the Rad55-Rad57 dimer [47]. The Rad51 filament then invades a 
homologous donor, creating a displacement  (D) loop [48], assisted by Rad54 [49], in which one of 
the invading strands displaces one of the donor strands and pairs with the other.  
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Depending on the initial conditions, this D-loop can then be resolved in different manners (Figure 
1.2), but in general the mechanism is that the invaded strand is used as template to extend the 
invading strand by DNA synthesis and the process is finished by gap filling and ligation [46], 
however the involved protein machinery will not be described. The D-loop can be resolved in 
different ways, depending on several conditions. For a DSB with two ends there is in general two 
ways to resolved it. In synthesis-dependent strand-annealing (SDSA) only a single strand invades, 
and after extension it dissociates from the D-loop resulting in non-crossover event in which the 
donor sequence is unchanged [45,50]. In double-strand break repair (DSBR) the displaced strand is 
then invaded by the other overhang, resulting in a double holliday junction (dHJ). From that point 
one option is a dissolution of the dHJ which results in non-crossover event or the resolution of the 
dHJ which can result in either a crossover event or a non-crossover event [45]. A third mode of 
repair is break-induced replication (BIR) assisted by Rad54 which happens in the case of a DSB 
with only a single end, which typically happens as a result of a collapsed replication fork [45]. In 
BIR one strand invades and both the invaded and the displaced strand are used as template for 
repair in a manner similar to leading and lagging strand in DNA synthesis. This results in the entire 
chromosome arm being replicated, potentially leading to chromosomal rearrangement or loss of 
heterozygosity [45]. 
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Figure 1.2 Models for DNA DSB repair by HR. A) After resection one strand invades and forms a D-loop. B) Synthesis-
dependent strand annealing. A single strand invades and after extension, dissociates from the D-loop causing a non-
crossover event. C) Double strand break repair. One strand invades, creating the D-loop, and then the displaced strand 
is also invaded forming a dHJ. The dHJ can be resolved in two ways, causing either a cross-over or a non-crossover 
event depending on the resolution. Alternatively a dissolution of the dHJ can happen, resulting in a non-crossover 
event. D) Single strand annealing. No D-loop formation happens. Instead resection reveals repeats which invades each 
other, resulting in the loss of the intervening DNA. 
Two other scenarios are of particular interest. Single strand annealing (SSA) is the model that 
accounts for recombination between two direct repeats and which is the mechanism that allows 
excision of counter-selectable markers flanked by direct repeats. SSA unlike the other models for 
HR does not involve the formation of the D-loop, but instead each one of the repeats that are 
exposed by resection can pair with the other leading to the loss of one repeat and the intervening 
sequence [50]. 
The other scenario of interest is that of what happens during gene targeting, specifically what is 
called ends-out recombination, in which a double ended substrate with flanks of homology ends up 
substituting what is between the sequences in the chromosomal location matching the flanks. Both 
ends invade the homologous regions [51], however the exact method of resolution is not clear and 
might also be species dependent. 
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Microhomology mediated end-joining 
Microhomology mediated end-joining, is also known as alternative non-homologous end-joining, 
since it was originally thought to be a backup mechanism for NHEJ, when classical NHEJ was 
unavailable. Unlike NHEJ, MMEJ is neither dependent on Ku or Lig4 [52]. MMEJ is initiated by 
resection similar to HR, by many of the same proteins as HR [52], and like both of the other two 
pathways MRX is involved. Where the two pathways separate is when it comes to RPA. Resection 
can reveal microhomologies of 5-25 bps [45] which can spontaneously anneal, however this 
spontaneous annealing is prevented by RPA [52]. Mechanically MMEJ a bit similar to SSA. MMEJ 
is a much more mutagenic pathway than HR or NHEJ, since it always results in deletion of the bp 
between the microhomologies, and it can even lead to translocation [37]. 
 
Choice of repair pathway 
Several factors affect the choice of repair pathway in the case of a DSB. One of the big ones is the 
species in question, and also the cell type in multicellular species [53]. Another important factor is 
the cell cycle. In G1 phase resection seems to be reduced [37], favoring NHEJ, while resection is 
active in S and G2 phase which corresponds to those phases in which sister chromatid is present 
[45]. Another major factor is the type of break to be repaired, for instance modified ends can 
present a hindrance for the Ku heterodimer and such repair by NHEJ [37]. 
 
Manipulating DNA for improved gene targeting 
The yeast S. cerevisiae is a prime example of an organism very amenable to genetic engineering, 
since when introducing extraneous DNA it will be integrated by HR with very high frequencies, 
even with very short flanks of homology [54]. Unlike S. cerevisiae, the various Aspergilli is not 
nearly is as amenable, integrating foreign DNA primarily by NHEJ, even if using long (1000-2000 
bp) flanks of homology. With wildtype gene targeting frequencies ranging from 0% to 40%, it was 
a huge game changer for the ability to do genetic engineering in many species of filamentous fungi, 
including Aspergilli, when it was discovered that the disabling of one of the unique components in 
the NHEJ pathway, could greatly enhance gene targeting frequencies [55–58]. Viable targets for 
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disruption includes  Ku70, Ku80 or LigD, and when one of these are disabled, greatly enhanced 
gene targeting frequencies are observed, In many cases close to a hundred percent depending on 
flank length of the gene targeting substrate and the specie in question. Similarly it has been 
attempted to increase gene targeting frequencies by upregulating the HR pathway rather than 
disabling NHEJ. In A. nidulans, by over-expressing the Rad51 homolog, uvsC, a modest increase in 
gene targeting frequencies were observed (from 5.9% to 26.9% and from 9.0% to 17.3%), not 
comparable to the effect observed by disabling NHEJ [59]. Furthermore both the thickness of the 
mycelia and conidiation was affected by the uvsC overexpression. While less severe, disabling of 
NHEJ is not without side-effects. While morphology is generally unchanged, several Aspergilli, 
including A. oryzae [60], A. luchuensis [61], A. aculeatus [62] and A. fumigatus [58] show increased 
sensitivity to methane methyl sulfonate (MMS), which is believed to stall the replication fork. 
Furthermore the Ku proteins, besides their involvement in NHEJ is also involved in telomeric 
maintenance, and the lack of Ku protein can cause telomeric shortening or sometimes lengthening 
in many organism including S. cerevisiae [41],  A. nidulans [63], plants and mammals [42,64]. 
Genome editing technologies 
An alternative to enhance gene targeting by manipulating the DNA repair pathways is instead to 
stimulate DNA repair at the desired location by causing a DSB at that locus. There are several gene 
editing technologies available, but in common for all of them are that they are all based on inducing 
a DSB at a specific location and then either cause small indel formation due to error-prone NHEJ or 
stimulate HR by addition of a homologous repair template. The creation of a DSB at a specific 
location is an incredible powerful tool, since then the cell’s DNA repair can be harnessed to 
facilitate various modifications in the genome. This allows for modifications in organisms 
otherwise not amenable to genetic engineering. If a DSB is repaired by MMEJ or NHEJ, there is the 
chance for small insertions or deletions (indels) at the sites, especially if the causing agent is still 
present, since then only a mutation can stop repeated cutting, and then the function of the gene in 
question is likely to be disrupted by frameshift mutations. Alternatively by providing a homologous 
DNA template to stimulate repair by HR, it is possible to do targeted deletion, integrations or point 
mutations. A third approach is based on utilizing the MMEJ  for doing targeted integrations [65]. 
Much of the motivation for developing genome editing tools comes from the desire to modify 
mammalian systems, which is notoriously difficult to engineer, but can provide valuable disease 
models, production host for various pharmaceutical or plants which can be of great agricultural or 
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commercial interests. In filamentous fungi the situation is different, since genetic engineering is 
feasible, but depending on various factors, can be time consuming. However depending on how 
resource intensive the technology in question is, it has the potential to be interesting for the 
possibility to make it easier to manipulate organisms as well. 
The most common gene editing technologies include mega-nucleases, zinc-finger nucleases (ZFN), 
transcription activator-like effector nucleases (TALENs) and recently, clustered regularly 
interspaced palindromic repeats/ CRISPR-associated protein (CRISPR-Cas9). 
Meganucleases 
Meganucleases are a type of nucleases, characterized by their very long , 12-40 bp recognition sites 
[66]. An example of some of these meganucleases are the homing endonucleases, which are very 
specific nucleases, part of a mobile genetic element, encoded in introns or inteins, to facilitate the 
spread of that element to a specific targeting site by gene conversion [67]. A commonly used 
homing endonuclease is I-SceI, which originates from an intron in S. cerevisiae mitochondrial 
DNA[68]. While the long recognition sites, makes the meganuclease extremely specific, it is also 
one of the main disadvantages since the chances are that such a recognition site is present at the 
desired locus is next to none. As such many applications of meganucleases are based on pre-
engineering a recognition site into the locus [69,70], and as such, while useful, its application for 
genome editing is limited. 
Zinc-finger nucleases 
Zinc-finger nucleases are fusion proteins, combining zinc-finger DNA binding domains with the 
cleavage domain of the FokI endonuclease [71]. Unusual for the FokI endonuclease is that the 
cleavage domain is separate from the DNA binding domain [72] and while it may exist in solution 
as a monomer, DNA cleavage only happens upon dimerization [73]. Further work has been done to 
promote hetero-dimerization over homo-dimerization [74,75], allowing for more specific cleavages 
by combing two different DNA binding domains. The underlying concept behind ZFN, is the 
Cys2His2 Zinc finger protein, where each zinc-finger recognizes three base pairs, and which can be 
assembled in a modular  fashion [71,76]. For each monomer of FokI, generally three to six zinc-
finger domains can be assembled, and then combined with a different monomer, for a hetero-dimer 
recognizing up to 36 bp [76]. The concept is illustrated in Figure 1.3A. Each zinc-finger motif 
consist of 30 amino acids with seven residues conferring the specificity for a certain triplet [77]. 
Despite the seemingly straightforward and modular design, several challenges are involved in the 
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design of functional ZFNs. One issues is that the sequence specificity and affinity are context 
dependent based on the neighbors ZFs, and that some configurations can lead to overlap in the 
targeting site [77] A main disadvantage of ZFN is the effort required to design and validate each 
ZFN, making it a costly process, preventing widespread use [78].  
 
Transcription activator-like effector nucleases 
TALENs are like ZFNs, hybrid proteins combining the FokI cleavage domain, with the 
transcription activator-like effectors (TALE) domains, from the plant pathogen Xanthomonas spp. 
In nature the TALE proteins are secreted to the plant, where they modulate expression of genes 
which supports bacterial virulence [79]. The DNA binding domain of the TALE proteins consists of 
small repeat region of most commonly 34 amino acids, however repeats from 30 to 42 amino acids 
exist [79], however the 12th  and 13th are said to be hypervariable. These repeated regions are 
assembled in a modular fashions, and each repeat, depending on the hypervariable residues 
facilitate binding to a specific nucleotide, with hypervariable regions existing which allows for 
binding to any nucleotide or a subset of nucleotides. As such a consecutive array of these repeats 
facilitates binding to a consecutive DNA sequence, as illustrated in Figure 1.3B. Once the 
relationship between hypervariable regions and DNA binding was figured out [80,81], these binding 
domains, like ZFNs, have been fused to the FokI cleavage domain to create hybrid nucleases 
[82,83]. While TALENs are significantly easier/cheaper to engineer compared to ZFNs, the highly 
repetitive nature of the proteins presents a challenge since many cloning methods does not deal well 
with repetitive DNA. 
 
Clustered regular interspaced palindromic repeats 
CRISPR-Cas9 is the newest system for genome editing, but has rapidly gained popularity due to its 
simplicity. The genome editing tool originates from an adaptive immune defense system found in 
approximately  40% of bacteria and 90% of archaea [84]. The name refers to small DNA repeats, 
separated by spacer DNA and these structures were first discovered in 1987 in Japan in Escheria 
coli [85] and later in other prokaryotes and archaea [86], however their function was unknown. The 
function as an adaptive immune system was proposed in 2005 with the discovery that most of the 
spacer sequences was of plasmid or viral origin [87–89] together with the fact that these loci are 
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transcribed [90] and the term CRISPR was coined. A number of CRISPR associated (cas) genes 
was identified, including proteins with nucleases helicases domains. There are several types of 
CRISPR immune systems, the type used for genome editing and thus the type described in this 
section is a type II CRISPR immune system, but type I and III also exist [91]. Functionally the type 
II system works by uptake of invading DNA, which is then incorporated as spacers into these 
CRISPR arrays between direct repeats [91,92]. The arrays are then transcribed and matured into 
crispr RNA (crRNA), which consist of a repeat and a spacer. Another RNA, called a trans-
activating CRISPR RNA (tracRNA), forms a duplex by basepairing with the repeat part of the 
crRNA, called a guide RNA (gRNA) [91,92]. Cas9 is a RNA-guided ribonuclease, and when it 
forms a complex with the gRNA, it can bind to DNA matching the spacer sequence, if the target 
DNA is followed by a protospacer adjacent motive (PAM), for which the specific sequence is a 
specific homolog of Cas9, and cleaves the target DNA [93]. This PAM sequence protects the cells 
from autoimmunity, ensuring that the CRISPR arrays will not be cut by the Cas proteins. 
 
CRISPR for genome editing  
The ability to target a specific sequence for cleavage by basepairing is incredible appealing, greatly 
simplifying the design compared to ZFNs and TALENs. Specifically for the Streptococcus 
pyogenes Cas9, which was the first one to be adapted to genome editing [94–98], the protospacer  is 
20 bp, which at the genomic locus should be followed by a PAM sequence consisting of NGG 
(NAG works as well, but with lower efficiencies [99]). As such, by exchanging only 20 bp, the 
Cas9 can be reprogrammed to a new target, being far easier and a lot cheaper compared to other 
genome editing technologies.  
For genome editing the system has been simplified making a single chimeric gRNA, connecting the 
crRNA with the tracRNAs with a hairpin loop [93], making it only a two component system rather 
than three, with a single guide RNA (sgRNA) and the Cas9 nuclease, illustrated in Figure 1.3C. 
While the S. pyogenes Cas9 was the first to be used for genome editing, other variants of the system 
have similarly been used. Some of these systems have different PAM usage, and examples includes 
CRISPR-Cas systems from Streptococcus thermophilus, Neisseria meningitidis and Staphylococcus 
aureus [100,101], with the last one being particular interesting due to the Cas protein being about 
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25% smaller than that of the S. pyogenes Cas9, due to size limitation in some vector systems. 
 
Figure 1.3 Three types of programmable genome editing technologies. A) ZFs assembled in a modular fashion and 
fused to FokI. Each ZF binds a DNA triplet. B) TALEs assembled in a modular fashion and fused to FokI. Each TALE 
recognize one base. C) CRISPR-Cas9. 20 bases of the sgRNA binds to the genomic target by basepairing. The remaining 
part of the sgRNA is in complex with the Cas9 protein, directing cleavage of the target DNA.  
Off-targeting 
Off-targeting is an important concern for all types of genome editing technologies, since the 
introduction of a DSB in the wrong position can lead to undesired mutations. There are two aspects 
to consider regarding off-targeting. One aspect, which technically is lack of the necessary 
specificity, rather than off-targeting, is the length of the targeting sequence, since for short targeting 
sequences, especially in large genomes the chance of the same sequence occurring more than once, 
can be high. The “real” off-targeting issues stems from the fact that basically all of the genome 
editing technologies have issues with the respective nuclease that sometimes cleaves sequences, 
while similar, is not an exact match to the recognition sequence. Lots of work has been done to limit 
off-targeting in the various genome editing technologies.  
Both ZFNs and TALENs are assembled in a modular fashion and both relies on the FokI 
endonuclease. That have also dictated the two main focus areas for increasing specificity. One focus 
has been on assembling enough modules, ZFs or TALEs, increasing the recognition site to get 
sufficient specificity, which is also related to genome size. The other common factor is the FokI 
endonuclease, which have been engineered to be an obligate heterodimer, essentially doubling the 
recognition site [75,102]. Similar strategies have also been applied to the CRISPR-Cas9. The Cas9 
nuclease have two domains each responsible for cleaving one of the DNA strands [93]. One strategy 
is based on inactivating one of these domains, turning the nuclease into a nickase, in combination 
with two sgRNAs with will cause two nicks on opposite strand which can stimulate gene targeting 
similar to a single DSB [103]. Another strategy, similar to that of ZFNs and TALENs is based on 
inactivating both cleavage domains of Cas9 and instead fusing it to FokI, so that basepairing of two 
sgRNAs in close proximity is necessary to cause cleavage by FokI [104]. 
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However, when it comes to the off-targeting issues, the main focus has been on predicting the 
parameters for when it happens. Especially ZFNs is tricky since the individual ZFs have affinity for 
more than one triplet [105], in addition to the effects from neighboring ZFs. To optimize ZFNs the 
focus have been on designing various platforms for efficient selection of ZFNs [106–108]. For 
TALENs off-targeting is likewise an issue, but the extent of it is still largely undiscovered [109]. 
For the CRISPR-Cas9 lots of effort has been put into figuring out the conditions triggering off-
target cleavage, and while the specificity of CRISPR-Cas9 might be less than that of TALENs 
simply due to the fact that CRISPR-Cas9 cleavage is based on a 22bp recognition sites, while that 
of a TALEN can be significantly longer 24-40bp [110], since targeting is based on basepairing 
potential off-targets can more easily be predicted. Considering CRISPR-Cas9 is based on an 
immune system, it might make sense that some degree of mismatching is tolerated to limit 
pathogens escaping by mutating. Two studies found that while mismatches generally are not 
tolerated in the PAM proximal end, while up to three mismatched in the PAM distal end could be 
tolerated [99,111]. Another studies found that 2bp mismatches caused no or very little off-targeting 
[112], and studies in S. cerevisiae or CHO cells found that off-targeting was not an issue [113,114]. 
Overall this shows that there is still a lot to figure out regarding off-targeting with CRISPR-Cas. 
 
Genome editing in Aspergillus 
While the first reports on the use of CRISPR-Cas9 for genome editing came out in the start of 2013, 
the first reports on CRISPR-Cas9 being used for the genetic engineering of filamentous fungi did 
not show up until mid 2015, and one of those is presented in chapter three. Furthermore until 
CRISPR-Cas9, genome editing technologies have not been used in filamentous fungi, except for a 
single report on the use of TALENs in Pyricularia oryzae [115]. Compared to previous genome 
editing technologies the cost and effort of using CRISPR-Cas9 is low enough that it is being applied 
to organisms otherwise amendable to genetic engineering with great results, such as S. cerevisiae 
[113,116,117], while it has greatly transformed genetic engineering of plant and mammalian 
systems [91]. This shows great promise that it will also turn out to be a valuable tool for genetic 
engineering of filamentous fungi. 
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Chapter 2: Intronic insertion as a tool for creating 
transient gene disruptions 
 
Introduction 
The ability to transiently disable a gene of choice can be a valuable tool for many purposes. Options 
include disabling of nutritional important genes to create auxotrophic selection markers, disabling 
of genes in the non-homologous end-joining (NHEJ) pathway to facilitate high frequencies of gene 
targeting or temporarily insertion of genes that you eventually would like to get rid of. Previous 
work in the field has been done to transiently disable pyrG in A. niger [1] for creating a strain 
auxotrophic for uridine, but resistant to 5-FOA. Likewise, nkuA in A. nidulans has been transiently 
disabled for boosting gene targeting frequencies [2]. These transient disruptions help bridging the 
needs between strains having traits suitable for genetic engineering with that of strains being 
suitable in an industrial setting. Unfortunately, the two approaches are mutually exclusive since 
both are taking advantages of the selectable and counter-selectable properties of pyrG as a 
nutritional selection marker and direct repeat recombination for excision. An alternative to relying 
on direct repeat recombination, is to take advantage of recombinases, such as the cre-lox, from the 
P1 bacteriophage [3], the FLP-FRT from the S. cerevisiae 2µ plasmid [4,5] or the β-six first isolated 
from S. pyogenes [6]. These recombinases, despite their very different origin, have each been shown 
to work in a wide range of species, including outside the kingdom in which they were isolated [7]. 
In general, these systems are two component systems consisting of a recombinase and a recognition 
sequence, and works by the recombinase catalyzing DNA combination between two of the 
recognition sites. The exact effect depends both on the specific system and on the orientation of the 
sites. For example for the cre-lox systems, if two loxP sites are in direct orientation and the cre 
recombinase is present, it will catalyze an excision event between the loxP sites, while if the loxP 
sites are inverted in regards to each other, the cre recombinase will facilitate an inversion on the 
DNA between the two sites [8]. 
A disadvantage to recombinase facilitated recombination over direct repeat combination is that 
while direct repeat recombination can be designed to leave no scar, recombinase facilitated 
recombination will leave one recognition site at the locus. However, unlike direct repeat 
recombination, the recombination frequencies are high enough to allow for successful 
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recombination events to be identified without the need for selection. Another useful feature is that it 
is possible to do multiple recombinase excision events at once. Therefore, to circumvent the issues 
with leaving a scar behind, we hypothesized that it will be possible to temporarily disrupt the 
function of a gene by inserting a marker gene into the gene of choice. We expect that the dramatic 
increase in intron size will interfere with intron splicing and lead to aberrant transcripts and thus no 
functional protein. To avoid impairing gene function permanently, by flanking the marker with loxP 
sites and target it to an intron, later excision by cre mediated recombination, leaving only the loxP 
scar in the intron, the function can be restored since the loxP scar is most likely small enough not to 
disrupt splicing of the intron. The whole concept is illustrated in Figure 2.1. Similar concepts have 
been utilized in both S. cerevisiae [9] and mouse models [10]. Despite the potential applications of 
transient knockouts based on intron-blocking, such a concept has not been applied to filamentous 
fungi before. 
 
Figure 2.1  Concept for intron based transient gene disrupting. A) Wildtype situation, introns on the DNA levels, get 
spliced out on the RNA levels. B) A marker gene flanked by loxP sites and inserted into the intron by HR, and this 
blocks successful splicing and thus also translation.  C) Exposure to the cre recombinase will excise the inserted marker 
gene from the intron, leaving only a single loxP scar. If placed correctly this will lead to successful splicing, similar to 
the wildtype intron. 
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Results 
Proof of concept, transient disruption of yA 
To test if the idea was feasible, the first objective was to make a transient disruption of the yA 
pigment gene in A. nidulans as a proof of concept. Donor, acceptor and splice sites were identified, 
based on consensus sequences found by Kupfer et al  [11], since we hypothesized that if any of 
these elements were disrupted by the loxP scar, which would eventually be left behind, it would not 
be tolerated, regarding intron splicing. Two DNA constructs, pyA-i2::pyrG and pyA-i3::pyrG were 
made containing a pyrG selection marker, from A. fumigatus, flanked by two loxP sites in direct 
orientation, flanked by two targeting sequences targeting the vector to either the second or the third 
intron in yA. The recipient strain, NID1 (Figure 2.2, panel A) was defective for NHEJ and 
auxotrophic for arginine, uridine and uracil, and all transformed colonies from both constructs 
(Figure 2, panel B and D), turned yellow indicating that yA has been successfully disrupted. Two 
colonies of each, (NID2010 and NID2011 disrupted in the second yA intron and NID2012 and 
NID2013 disrupted in third yA intron) and were purify streaked, subjected to protoplastation and 
transformed with pCCM1, an AMA1 vector containing the cre recombinase under control of the A. 
nidulans gpdA promoter and the argB selection marker. After transformation, the resulting colonies 
from all four strains were green (Figure 2, panel C and E). However a minority of the colonies 
displayed few specks of yellow, demonstrating that a loxP scar through careful placing could be 
tolerated in the intron. 
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Figure 2.2 Proof of concept for transient gene disruption. A) Stab of NID1. B) Transformation plate of NID1 
transformed with pyA-i2::pyrG, disrupting yA in the second intron, resulting in a yellow-spored phenotype. C) 
Transformation of one of the yellow colonies from panel B, with a vector containing the gene encoding the cre-
recombinase, restoring the green-spored phenotype. D) Similar as B, but the vector facilitate a disruption of the third 
yA intron instead. E) Transformation of one of the yellow colonies from panel D, with a vector containing the gene 
encoding the cre-recombinase, restoring the green-spored phenotype. 
 
To ensure that the loxP scar left in the intron did not affect expression levels of the transiently 
disrupted gene, qRT-PCR was performed comparing expression of wildtype yA with a of a yA allele 
possessing an intron scar from transient disruption (Figure 2.3). The actA and hhtA genes where 
used for normalization. One colony from each of the recovered yA disruptions (NID2014 and 
NID2015 with a loxP scar in second intron and  NID2016 and NID2017, with a loxP scar in third 
intron) , were purify streaked, RNA was purified and used for qRT-PCR. Three out of the four, 
showed expression levels similar to the wildtype yA gene, while the fourth, NID2017, with a loxP 
scar in the third intron showed a somewhat lower expression levels. However, the NID2017 RNA 
was also of lower quality than the other samples. While the data does not conform to MIQE [12], 
this strongly suggests that this method of transient disruption is feasible. 
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Figure 2.3 Test of yA expression in four strains in which yA have been restored. A) and B) shows the expression of yA in 
different transformant formerly disrupted in the yA second intron, while C) and D) are from two different 
transformants formerly disrupted in the third intron. Numbers are relative to yA expression in NID1 and two different 
household gene were used for normalization. 
 
A Self-excising intron disruption cassette 
While the above experiment provided proof of concept that introns could be used for transient 
disruptions of genes, it would be convenient if it did not require an additional cycle of 
protoplastation and transformation. Two DNA constructs, pyA-i2::tet-cre-pyrG and pyA-i3::tet-cre-
pyrG were made containing, the cre recombinase under control of the fungal optimized tetON 
promoter [13] and a pyrG selection marker. These three elements were flanked by loxP sites in 
direct orientation and targeted into either the second or third intron, the exact same location as 
above. Linearized vector was transformated into NID1, disrupting either second or third intron and 
both transformations readily yielded yellow colonies (Figure 2.4, panel A and B), and when purify 
streaked they remain phenotypically stable, resulting in NID2018 and NID2019 respectively. 
However, when grown over long time, more than three weeks, few green spores could be seen in 
the microscope in the yellow colonies, which could potentially be due to either leakage of the 
promoter or a direct repeat recombination event in the tetON promoter, leaving only the gpdA 
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promoter causing constitutive expression. This is possible since the A. nidulans promoter is used 
both driving expression of the trans-activator and expression of the gene of choice [13], creating a 
direct repeat. When yellow colonies where transferred to non-selective media with doxycycline, 
inducing the tetON promoter, the colonies having second intron disrupted remained yellow, whereas 
those disrupted in the third intron of yA readily turned green (Figure 4, panel C and D). One colony 
of each were purify streaked and saved as NID2020 and NID2021.Considering that what will be left 
from the loxP-pyrG-loxP and the loxP-tetON-cre-pyrG-loxP, after cre mediated excision, is exactly 
the same, loxP, it was strange that one of the second intron disruption constructs readily worked 
while the other did not. Six colonies from the second intron disruption was transferred from the 
doxycycline containing media to MM-arg, however only a single one was able to grow, suggesting 
that pyrG had been removed from the others and that for the most part incomplete excision of the 
insert was not the reason for the inability to restore function of the disrupted gene. 
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Figure 2.4 Self-excising intron disruption cassette. A) and B) shows transformations in which the second or third intron 
of yA, respectively, have been disrupted with the cre recombinase gene under control of the tetON promoter and 
pyrG selection marker. C) and D) shows colonies from A) and B) respectively, which after streak purifying are plated on 
non-selective media containing doxycycline, inducing the tetON promoter. 
 
Transplanting introns to other genes 
To figure out how far this concept can be pushed we decided to see if is possible to insert or replace 
one intron with another intron in the A. nidulans wA gene, which if disrupted gives rise to a white 
spored phenotype. We used the vector containing the third intron of yA with the loxP-tetON-cre-
pyrG-loxP insert as template and constructed four vectors either inserting the intron at a location in 
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wA which does not contain an intron or tried to replace an existing intron with the modified yA 
intron. Two vectors allowing for insertion on the yA intron either between the 86th and the 87th bp or 
the 1933th and the 1934th of the wA gene were made, pwA-II1 and pwA-II2, while two other 
vectors, replacing either the first or the third intron of the same gene, pwA-IR1 and pwA-IR3 were 
similarly made. 
All four vectors were transformed into NID1. Transformants from all four transformations 
displayed a white phenotype consistent with wA disruption (Figure 2.5, panel A-D), and they were 
purified streaked unto selective media, and one colony of each saved as  NID2022, NID2023, 
NID2024 and NID2025. Afterwards each of the colonies and one other from the same 
transformation plate, were streaked on non-selective media (MM-arg-uri-ura) containing 
doxycycline, to see if excising out the tet-cre-pyrG could restore wA function, leading to a green 
phenotype. The strain carrying the construct for replacing the first intron in wA with the third intron 
of yA readily turned green again, while the other three strains remained white-spored (Figure 5, 
panel E-H). Colonies from all eight were purified streaked onto selective MM-arg media, to see 
whether failure to restore wA function could be result of a failure to excise the tet-cre-pyrG cassette, 
which could be indicated by an ability to grow on media not containing uridine and uracil. Two of 
each of the doxycycline exposed colonies were stabbed to minimal media containing arginine, but 
no uridine or uracil. The colonies which successfully had wA function restored, unsurprisingly did 
not grow since the pyrG marker has to be excised for intron splicing to be restored, however for the 
remaining colonies, one of each transformants grew, while the others did not.  
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Figure 2.5 Intron transplantation. A) and B) shows transformation plates where NID1 is transformed with the vectors 
pwA-ii1 and pwA-ii2, inserting the third yA intron with the tetON-cre-pyrG insert into two different sites in wA. C) and 
D) shows transformation plates of NID1 transformed with the vector pwA-ir1 and pwA-ir3, where either the first or 
the third intron of wA is replaced with the third yA intron with the tetON-cre-pyrG insert. E), F), G) and H) shows 
colonies from A), B), C) and D) respectively, which after streak purifying are plated on non-selective media containing 
doxycycline. 
 
Creating a strain transiently disrupted in pyrG and nkuA 
One potential application of intron based transient disruption, would be to simultaneously disrupt 
pyrG and nkuA, the ku70 homolog in A. nidulans, to get a strain with suitable traits for genetic 
engineering, with high frequencies of homologous recombination (HR) and a counter-selectable 
selection marker, but which could be cleaned up afterwards. While including the cre gene under 
control of the tetON promoter was an option, we decided instead to rely on later introduction of cre, 
to avoid potential issues with leakiness.  
First a vector was made, pNid-pyrG::ble containing the bleomycin marker gene flanked by loxP 
sites and sequences for targeting the one intron in the A. nidulans pyrG gene. The construct was 
transformed into NID730, which is wildtype except for the veA1 mutation[14], selecting for 
bleomycin resistance. Resulting colonies were transferred to 5-FOA containing media. Of 15 
colonies transferred to 5-FOA, one had the ability to grow on the media and this transformant was 
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confirmed by PCR, and after streak purifying the resulting strain named NID1763. A challenge for 
testing whether the disruption is transient or not, is that pyrG is the only easily available selection 
marker. This makes it difficult to discern whether the pyrG prototrophy originates from the original 
pyrG gene being restored or from the pyrG gene introduced with the cre recombinase vector. The 
resulting strain, NID1763 was protoplasted and transformed with an AMA1 based vector, pCCM2 
containing the cre recombinase encoding gene under control of the A. nidulans gpdA promoter and a 
pyrG selection marker. After transformation, selecting for uridine and uracil prototrophy, four 
transformants were two times re-streaked without selection to lose the AMA1 plasmid, since it is 
very unstable, even with selection it is readily being lost [15]. Afterwards the colonies were 
transferred to both minimal media and 5-FOA. All four colonies grew on MM, but not on 5-FOA. If 
the uridine/uracil prototrophy originated from the pyrG gene on the AMA1 plasmid it should have 
been lost during growth without selection, and even if still present, it should readily be lost upon 
growth on 5-FOA. Instead if the uridine/uracil prototrophy was due to the native pyrG gene being 
restored, it should be able to grow even after growth without selection, while when transferred to 5-
FOA, without a way to get rid of the pyrG activity, it would be unable to grow. Furthermore, PCR 
confirmed that the bleomycin marker gene had indeed been excised. One colony was saved as 
NID2026. This strongly indicates that the pyrG gene could be transiently disrupted and then 
subsequently restored. 
Next vectors, pNid-nkuA::hyg-pyrG-up  and pNid-nkuA::pyrG-dw for transient disruption of nkuA 
was constructed. Since the strain was now pyrG deficient, pyrG could now be used for selection and 
afterwards recycled if flanked by direct repeats. However, since it is unclear how large an insert is 
needed to disrupt intron splicing, and the repeat left behind is only approximately 500 bp the 
hygromycin marker gene was additionally inserted, as filler DNA. To improve gene targeting 
frequencies, and since there is no obvious phenotype for nkuA disruption, rather than constructing 
one vector, two vectors were made for bipartite gene targeting [16]. One containing an upstream 
sequence for targeting the second intron of nkuA, the hygromycin marker, the first repeat and part of 
the A. fumigatus pyrG gene, and the other vector containing the other part of pyrG with some 
overlap, the second repeat and the downstream sequence for targeting nkuA. The strain with the 
transient pyrG disruption, NID1763, was transformed with both vectors, selecting for uridine/uracil 
prototrophy. In total 16 colonies were purify streaked and analyzed by PCR. A single colony 
showed the bands corresponding to a correct integration event. The transformant was plated on 5-
FOA to excise the pyrG marker and a colony was isolated. It was checked by PCR that the new size 
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of the insert was consistent with the hygromycin marker gene and a single repeat from pyrG. The 
new strain, NID1764 was protoplasted and transformed with a vector for deleting yA, p6f-yA  [17]. 
The transformation resulted in 12 yellow-spored colonies and a single green-spored one, indicating 
a gene targeting frequency above 90%, consistent with the phenotype also seen when deleting nkuA. 
The strain, NID1764 was likewise transformed with pCCM2 and the successful excision on the 
inserts in both nkuA and pyrG was confirmed by PCR. Unfortunately, due to time-constrains I did 
not get to test whether the nkuA disruption were actually reversible or not, and such whether the 
resulting strain, NID2027 was NHEJ proficient again. 
 
Discussion  
The results presented here demonstrate that the concept for transient disruption by insertion into an 
intron is certainly viable. One thing that remains to be seen is the effect when multiple disrupted 
genes have to be restored at once, however at least in the yeast S. cerevisiae multiple 
simultaneously excision events by cre-lox is possible [18]. As such there is good reason to believe it 
will also work in Aspergillus, even if it also gets expanded for instance to include more selection 
markers such as argB. A potential risk, if the genes are located on different chromosomes, is that 
multiple excision events can cause a cross-over event, and thus chromosomal rearrangements. 
However, since the disruption is from an intron and such in the middle of a gene, cross-over events 
would still result in the disrupted phenotype, and for instance in the case of pyrG such an event is 
easy to detect. 
An important consideration is what the long term effects of such an inactivation are. Since the only 
loxP scar left is in the intron, the protein is completely unaffected, with no effects on either folding 
or localization. Preliminary qRT-PCR data on the restored yA gene, suggest that mRNA levels are 
not affected, and while analysis will have to be carried out for pyrG and nkuA and potential other 
targets, it is definitely promising. 
One interesting aspect is that the length of the insert seems to be of importance. When disrupting 
the second intron of yA, the exact same location that tolerated the insert consisting of pyrG alone 
(1474 bp) for reversible disruption, did not tolerated the longer insertion consisting of the tetON-
cre-pyrG construct (5072 bp), despite a majority of the colonies showing uridine and uracil 
auxotrophy. The auxotrophy suggests that the pyrG marker has been excised. Knowing why some 
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inserts can be tolerated and other not, would be very helpful. Sequencing of the site in some of 
those colonies that show the disruptant phenotype, but which still also shows uridine/uracil 
auxotrophy could shed light on why it does not work. The same is the case for the scenario where 
the replacement of one introns of wA with the third intron of yA, replacement of the first wA intron 
worked, while replacement of the third wA did not work.  
An alternative use for this transient inactivation, is to use it for transient insertion. For instance, 
having Cas9 inserted in the genome for genome editing could be very useful. However for a 
production strain, having a DNA binding protein permanently inserted, might not be desirable. As 
such, transiently inserting Cas9 into an intron could be an elegant solution. 
Ultimately while the concept still has some kinks it would be helpful to sort out, there is good 
reason to believe that this can be a valuable addition to the genetic engineering toolbox in 
Aspergillus. 
 
Materials and methods  
Strains and media 
Escherichia coli strain DH5α was used to propagate all plasmids. The Aspergillus nidulans strains 
used in this study are listed in Table 2.1. Genomic DNA (gDNA) from fungal strains were isolated 
via FastDNA SPIN Kit for Soil DNA extraction kit (MP Biomedicals, USA). The mutant strains 
made in this study are also listed in Table 2.1. All strains were cultivated on standard solid glucose 
based minimal medium (MM) (1% glucose, 1x nitrate salt solution [19], 0.001% Thiamine, 1x trace 
metal solution [20], 2% agar), supplemented with 10mM uridine (Uri), 10mM uracil (Ura), and/or 
4mM L-arginine (Arg) when required. Solid plates containing 5-fluoroorotic acid (5-FOA) were 
made as MM+Arg+Uri+Ura supplemented with filter-sterilized 5-FOA (Sigma-Aldrich) to a final 
concentration of 1.3 mg/ml. For transformation media (TM) glucose was replaced with 1M sucrose. 
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Table 2.1 List of strains used in the study 
Strain name Genotype Source 
NID1 argB2, veA1, pyrG89, nkuAΔ EMCB strain 
collection1 
NID730 veA1 EMCB strain 
collection1 
NID1763 veA1, pyrG::ble This study 
NID1764 veA1, pyrG::ble, nkuA::hph This study 
NID2010 argB2, veA1, pyrG89, nkuAΔ, yA::pyrG(i2) This study 
NID2011 argB2, veA1, pyrG89, nkuAΔ, yA::pyrG(i2) This study 
NID2012 argB2, veA1, pyrG89, nkuAΔ, yA::pyrG(i3) This study 
NID2013 argB2, veA1, pyrG89, nkuAΔ, yA::pyrG(i3) This study 
NID2014 argB2, veA1, pyrG89, nkuAΔ, yA(i2-loxP) This study 
NID2015 argB2, veA1, pyrG89, nkuAΔ, yA(i2-loxP) This study 
NID2016 argB2, veA1, pyrG89, nkuAΔ, yA (i3-loxP) This study 
NID2017 argB2, veA1, pyrG89, nkuAΔ, yA(i3-loxP) This study 
NID2018 argB2, veA1, pyrG89, nkuAΔ, yA::tetON-cre-pyrG(i2) This study 
NID2019 argB2, veA1, pyrG89, nkuAΔ, yA::tetON-cre-pyrG(i3) This study 
NID2020 argB2, veA1, pyrG89, nkuAΔ, yA(i2-loxP)? This study 
NID2021 argB2, veA1, pyrG89, nkuAΔ, yA(i3-loxP) This study 
NID2022 argB2, veA1, pyrG89, nkuAΔ, wA::tetON-cre-pyrG(ii1) This study 
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NID2023 argB2, veA1, pyrG89, nkuAΔ, wA::tetON-cre-pyrG(ii2) This study 
NID2024 argB2, veA1, pyrG89, nkuAΔ, wA::tetON-cre-pyrG(ir1) This study 
NID2025 argB2, veA1, pyrG89, nkuAΔ, wA::tetON-cre-pyrG(ir3) This study 
NID2026 veA1, pyrG(i1-loxP) This study 
NID2027  veA1, pyrG(i1-loxP), nkuA(i2-loxP) This study 
1 Strain collection of the Eukaryotic Molecular Cell Biology group, DTU Systems Biology, 
Contact person: Uffe Hasbro Morten 
 
PCR and USER cloning 
All vectors were constructed by PCR and USER cloning as described by Nødvig et al [17]. Detailed 
vector construction can be found in Appendix 2.1 and the primer used in Appendix 2.2. 
Placement of insert in introns 
To be on the side of caution, it was ensured that the first seven and the last six bps of the intron 
were avoided (consensus donor and extended acceptor sites are six and five bp in length 
respectively [11]). Likewise, all sequences matching the motive NNCTRAY were avoided to 
protect the splice site. If no motive was found matching NNCTRAY, NNYTRAY was used instead. 
Since the potential splice site in general is located close to the acceptor site, in all cases the insert 
was placed between donor and splice site. 
Transformation and strain validation by Tissue-PCR 
Protoplastation were performed as described by Nielsen et al [16]. Transformation using either 
pyrG or argB as genetic marker was performed as described by Nødvig et al [17], while for 
transformation utilizing bleomycin selection, 107 protoplasts and ~3 μg of digested DNA were 
incubated for 15 min on ice, then 1 mL PCT was added and the mix incubated for 15 min at room 
temperature. 12 μg/ml bleocin B (InvivoGen, USA) was added to 15 ml molten 1M sorbitol based 
TM (TMsh; ~45°C, pH 6.5), and immediately poured into an empty 9 cm petri dish. After 24 h 
incubation at 30°C, an overlay of 15 ml TMsh was added. All candidate transformants were streak 
purified prior to verification. All strains which were verified by PCR, was done by tissue-PCR 
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analysis using mycelium as described by Nødvig et al [17]. The use of primers is described in 
Appendix 2.1 and the primer sequences can be found in Appendix 2.2. 
Primers for gene disruption analysis were designed in two ways. One primer binds completely 
outside the sequence included in the gene targeting vectors, and the other binds either inside the 
insert or on the opposite side of the insert sequence. One setup detects only correct integration while 
the other detects both correct and failed integrations as well as heterokaryons. 
qRT-PCR 
RNA extraction and qRT-PCR was performed as described by Hansen et al [21]. RNA extraction 
was done by RNeasy plant kit (Qiagen, Netherlands) on five strains (Nid1 and two of each colonies 
where yA activity restored after disruption in second or third intron). 10 µg of RNA was treated 
with DNase I (Qiagen) and 1 µg was used for cDNA amplification by Phusion RT-PCR kit 
(Finnzymes, Finland). Afterwards quantitative reverse transcription-PCR (qRT- PCR) was 
performed in a Chromo 4 detector/PTC-200 apparatus (MJ Research, Canada) by using SYBR 
Green JumpStart Taq ReadyMix (Sigma, Germany). The A. nidulans actin gene, actA AN6542 and 
the histone 3 gene, hhtA AN0733 were the internal standards for normalization of expression levels. 
Three primer pairs were used, Any/A-qRT-3-F/ ANyA-qRT-3-R, ANhhtA-RT-R/ ANhhtA-RT-F2 
and ANactA-3'-F/ ANactA-3'-R, which can be found in Appendix 2.2. Samples were run in 
triplicates. The program was 94°C for 2 min and 40 cycles of 94°C for 10 s, 60°C for 15 s, and 
72°C for 30 s. A melting curve from 65°C to 95°C with reads every 0.2 min ended the program to 
evaluate the purity of the reaction products. The fluorescence threshold values (CT) were deter- 
mined by using the Opticon Monitor 3.1 software (MJ Research). The relative expression levels 
were approximated based on 2-ΔΔCT, with ΔΔCT = ΔCT(normalized) -ΔCT(calibrator), where ΔCT(normalized) 
=CT(target gene) -ΔCT(household gene).The calibrator CT values are those for the reference strain, NID1. 
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Appendix 2.1 Vector construction 
 
All vectors were assembled by USER cloning [1]. The vectors for insertion in the yA second intron 
were made in two steps. First part, containing the two targeting sequences with an AsiSI/Nb.BtsI 
between two loxP sites. Upstream targeting sequence was made by PCR amplification with 
CSN18+CSN19 and downstream by primers CSN48+CSN21 both from A. nidulans gDNA and 
both of these cloned into vector p1, assembling the loxP sites and the AsiSI/Nb.BtsI cassette in the 
USER primer tails. Similarly, a vector for insertion into the third intron of yA was made by 
amplification with primers CSN18+CSN49 for upstream sequence and primers CSN50+CSN21 for 
the downstream. These two vectors were then opened for further USER cloning by digestion with 
AsiSI and Nb.BtsI. For insertion of pyrG alone, pyrG from A. fumigatus was amplified from the 
vector pDEL2 [2] with the primers CSN22+CSN23 and cloned into both vectors. For the vectors 
also containing the cre recombinase and the tetON promoter, pyrG was amplified with primers 
CSN73+CSN23, the tetON promoter was amplified from pVG4-1 [3] in two parts with primers 
CSN59+96 and CSN97+CSN60, while the cre gene was amplified with primers CSN61+CSN62 
from template APC161. All four fragments were cloned into both vectors. 
For insertion of the third yA intron, with the tetON-cre-pyrG insert, into wA, the intron with insert 
was amplified from vector pyA-i3::tet-cre-pyrG, using primers CSN220+CSN96 and 
CSN97+CSN221. Gene targeting flanks for replacing either first or third intron of wA with the 
modified yA intron, was made by PCR using primers CSN276+CSN274 and CSN275+CSN277 for 
the first intron and primers CSN436+CSN434 and CSN435+CSN437 for the third intron, all 
amplified from A. nidulans gDNA. For the insertion of the modified yA intron as an extra intron in 
wA, flanks for the first insertion was made with primers CSN276+CSN432 and CSN433+CSN277, 
while the second insertion was made with primers CSN275+223 and CSN224+225 amplified from 
gDNA. 
For creating a vector for disruption of pyrG with the bleomycin resistance gene, upstream targeting 
sequence was amplified from A. nidulans gDNA, with primers CSN110 and CSN177, while the 
downstream targeting sequence was amplified CSN178 and CSN113. The bleomycin resistance 
gene was amplified from pAN8-1 [4] with primers CSN171 and CSN172, and the loxP sites 
assembled by the USER tails. 
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To create the vectors for disruption of nkuA, 5’ fragment and 3’of nkuA was amplified from gDNA 
with primers CSN51+CSN230 and CSN231+CSN54, the hygromycin marker gene was amplified 
from CSN171+CSN217 using pAN7-1 [5] as template, 5’ and 3’ parts of pyrG was amplified by 
CSN73+CSN298 and CSN297+CSN148 using pDEL2 [2] for template and repeats for direct repeat 
recombination was amplified with primers CSN215+CSN204 and CSN216+CSN205 using gDNA 
from S. cerevisiae CEN.PK113-11C as template. The 5’ nkuA fragment, the hygromycin marker 
gene, one of the repeat and the 5’ pyrG fragment was assembled in one vector and the 3’ pyrG 
fragment, the other repeat and the 3’ nkuA fragment in the other vector. 
 
Mycelia PCR for strain verification 
Correct insertion into the pyrG locus was verified using primers CSN162+CSN189 and primers 
CSN161+CSN189. Similarly, nkuA insertion was verified using primer CSN42+CSN190 and 
CSN155+CSN190 
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Appendix 2.2 Primer table 
Primers used in the study 
Primer name Sequence 
yA intron insertion 
CSN18 yA-i2-up-
fwd 
GGGTTTAAU ATGCTCGTCTTCCATCTCTGC 
CSN19 yA-i2-up-
loxP-AsiSI-
Nb.BtsI-rv 
ACTGCAT 
AACUTCGTATAGCATACATTATACGAAGTTATCGGAAAGGGCACA
CACTCTAA  
CSN21 yA-i2-down-
rv 
GGTCTTAAUTCCCAAACATCAACCCCGT 
CSN22 Af-pyrG-fwd AGAGCGAUCGTGGAGTTACCAGTGATTG 
CSN23 Af-pyrG-rv TCTGCGAUCTTGCTAGATGACTGGTAGG 
CSN48 yA-i2-down-
fwd2 
AGTTATGCAGUGAGAGCGATCGCAGACACTGC 
ATAACTTCGTATAATGTATGCTATACGAAGTTATCGTCCCATTTCT
GCATGGACCTAA 
CSN49 yA-i3-up-rv ATCGCTCUCACTGCATAACTTCGTATAGCATACATTATACGAAGTT
AT CTTCATCGTGCAGATAAGGTGTAAT 
CSN50 yA-i3-down-
fwd 
AGAGCGAUCGCAGACACTGCATAACTTCGTATAATGTATGCTATA
CGAAGTTA TCCCATTGAGGCAGTCTTATTGAT 
CSN59 tetON fwd AGAGCGAUAGCTTCGGAGAATATGGAGCTTCATCGA 
CSN60 tetON-rv AAACGGUGATGTCTGCTCAAGC 
CSN61 cre-fwd ACCGTTU ATGTCCAATTTACTGACCGTACACC 
CSN62 cre-rv acgaagtcu AACCTTACCCAAGAGTTCGCC 
CSN73 pyrG-U1-
fwd 
agacttcguCGTGGAGTTACCAGTGATTG 
CSN96 tetON-int-rv ATGAAGTTAAUGCATGGCAGACACTGAAGC 
CSN97 tetOn-int-
fwd 
ATTAACTTCAUCCTACTGTCCTACCCGCAG 
wA intron insertion or replacement. 
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CSN220 yA-i3-fwd AGTACGUCTGATCAGATTACACCTTATCT 
CSN221 yA-3-rv ACTATUGAGACATGATCAATAAGACTGC 
CSN222 wA-up-fwd GGGTTTAAU GGACCCATACCGTGTCTATCTCTT 
CSN223 wA-up-rv ACGTAC U ATCCATCGGCTCCGTCATC 
CSN224 wA-dw-fwd AATAG U TGCAGAGCAGATGGTGTTGG 
CSN225 wA-dw-rv GGTCTTAAU ACGGCTCTCAACGACTCTCTG 
CSN274 Anid-wA-i3-
ins-up-rv 
ACGTAC U TGATAAAACATCCCAATTGATATATGC 
CSN275 Anid-wA-i3-
ins-dw-fwd 
AATAG U TACTATGGTGACCTTGGTCATACATTC 
CSN276 Anid-wA-up-
fwd 
GGGTTTAAU TGACGCCAGCTCTCTTCCC 
CSN277 Anid-wA-
dw-rv 
GGTCTTAAU TCAGGAAACCGACCCGACA 
CSN432 wA-II1-up-rv ACGTAC UTCTTTGCCTGTAGCAGACGACG 
CSN433 wA-II1-dw-
fwd 
AATAG UCACTCTCTCCTTTCGAGCTTTCTC 
CSN434 wA-IRI3-up-
rv 
ACGTAC UGAAGGACAGAGTGCAGCTCCATT 
CSN435 wA-IRI3-
dw-fwd 
AATAG UCTCTTTATGCAGATAGTGCTCAAACC 
CSN436 wA-IRI3-up-
fwd 
GGGTTTAAU GGCATCATTAGGAATAACGCCAT 
CSN437 wA-IRI3-
dw-rv 
GGTCTTAAU GCAAACACCAGATCGTCAGACAT 
Transient pyrG and nkuA disruption 
CSN110 Nid-pyrG-i1-
up-fwd 
GGGTTTAAU CCCAGAAAATTGCCACATTAGACATTG 
CSN177 Nid-pyrG-
loxp-up-rv 
ATACATTAUACGAAGTTAT TGGTGCAGGATGTACGGTCAGC 
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CSN178 Nid-pyrG-
loxP-dw-fwd 
ATGTATGCUATACGAAGTTAT 
ATGCCCCTCCAGGATAACAAATAGC 
CSN113 Nid-pyrG-i1-
dw-rv 
GGTCTTAAUTTACTGGCAGGGTACACGGCTGA 
CSN171 gpdAp-loxP-
fwd 
ATAATGTAUGCTATACGAAGTTAT GCGTAAGCTCCCTAATTGGC  
CSN172 trpCt-loxP-rv AGCATACAUTATACGAAGTTAT 
TTACCTCTAAACAAGTGTACCTGTGC 
CSN51 nkuA-i2-up-
fwd 
GGGTTTAAUGGCACAGAGTTCGGCGTTG 
CSN230 nid-nkuA-i2-
up-rv 
ATACATTAU ACGAAGTTATCGAACGGTCTGACTTTGATTCA 
CSN231 nid-nkuA-i2-
down-fwd 
ATGTATGCU 
ATACGAAGTTATCGACCCTACTAATCACCAAATAGCACT 
CSN54 nkuA-i2-
down-rv:  
GGTCTTAAUCCACCTCCCGTCCACAATC 
CSN215 R1-L3-fwd aagtgtaau CAAACATCTACACAATTAGCAAGGG 
CSN216 R2-loxP2-rv AGCATACAUTATACGAAGTTAT 
GTTACACGGAAGGAGAGCAGTAAG 
CSN217 TtrpC-L3-rv attacactu TTACCTCTAAACAAGTGTACCTGTGC 
CSN204 R1-(L1)-rv acgaagtcu GTTACACGGAAGGAGAGCAGTAAG 
CSN205 R2-(L2)-fwd aagtctacu CAAACATCTACACAATTAGCAAGGG 
CSN73 pyrG-U1-
fwd 
agacttcguCGTGGAGTTACCAGTGATTG 
CSN148 pyrG-rv agtagactu CTTGCTAGATGACTGGTAGG 
CSN297 Af-pyrG-int-
PacI-fwd 
GGGTTTAAU TGATGATACAGGTCTCGGTCCC 
CSN298 Af-pyrG-int-
PacI-rv 
GGTCTTAAU GGAAGAGAGGTTCACACCCGT 
qRT-PCR primer 
 ANyA-qRT-
3-F 
CCACATCCGATCCATAAGCAC 
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 ANyA-qRT-
3-R 
CATGCCCCATCCATGAGC 
 ANhhtA-RT-
R 
GAGGCGACGAGCAAGCTG 
 ANhhtA-RT-
F2 
GTGCTCTCCAGGAGTCCG 
 ANactA-3'-F GACGTCCGTAAGGATCTGTACG 
 ANactA-3'-R GCGGTGGACGATCGAAGG 
Primers for PCR verification 
CSN155 nkuA-int2-
fwd 
AAGAGTCGGCGAGAAGTTGTTA 
CSN161 Nid-pyrG-
int1-fwd 
ACAGCCCAAAGCCTACAAAT 
CSN162 ble-int-fwd CGAGATCGGCGAGCAGC 
CSN189 Nid-pyrG 
out-rv 
CAATCCCTTAAAGCCTTCCGT 
CSN190 Nid-nkuA-
out-rv 
GAAGAAGAATCAGTGGATTGGGTC 
CSN42 Af-pyrG-
sq2-fwd 
TGTAGTGCCAGTACGAGTGTTGTG 
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Chapter 4: Expanding tools and applications of the 
CRISPR-Cas9 system in Aspergillus nidulans 
 
Introduction 
The genome editing technology CRISPR-Cas9 has recently been adapted for the use in various 
filamentous fungi [1–4]. So far, the focus has mainly been on finding a setup that allows for the 
bacterial/archaeal RNA-guided nuclease to be successfully used in these organisms and how to use 
it to either introduce mutations by faulty non-homologous end-joining (NHEJ) or by boosting 
frequencies repair by homologous recombination (HR). However in other cell systems such as S. 
cerevisiae or mammalian cell systems the CRISPR-Cas9 technology has been a useful tool since 
2013, and much more development has been done.  
One of the main concerns when using genome editing technologies such as the CRISPR-Cas9 
technology is the risk of creating unintended double-strand-breaks (DSB). Of course, this is a 
problem that scales with genome size, since specificity is determined by 20 bp. The bigger the 
genome is, the harder is it to find 20 unique bases in the desired location. There have been lots of 
efforts to come up with strategies to limit off-targeting and to gauge the scope of the problem. 
Strategies to limit off-targeting includes inactivating one of the sites in Cas9 responsible for 
cleaving one of the DNA strands, creating a nickase [5,6], essentially extending the target site when 
using two sgRNAs causing nicks in close proximity on opposite DNA strand. Similar but more 
elaborate is a strategy where both domains responsible for cleavage is inactivated, and the Cas9 
protein is then fused to a dimeric FokI nuclease [7,8]. The main differences between the paired 
nickases and Cas9-FokI fusions are that a single nickase can cause a nick by itself, and the distance 
between two nicks can be somewhat flexible, being able to induce HR or NHEJ with distances up to 
approximately  100 bp [5,6,9]. In comparison the Cas9-FokI fusion only induces a DSB when two 
monomers binds in close proximity, 10-25 bp apart [7,8]. A third strategy is based on truncating the 
protospacer down to 16-19 bp instead of the normal 20 bp, the argument being that with fewer 
based to provide basepairing, the lower the tolerance is for mismatches [10]. All three strategies 
have been shown to be able to reduce off-targeting effects. 
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Interestingly, to which degree off-targeting is a problem is still up for discussion. While some 
studies report off-targeting to be a problem [11,12], others do not. Two recent studies included deep 
sequencing of either S. cerevisiae or CHO cells at predicted off-targeting sites [13,14] showed no 
indel formation attributable to off-targeting of Cas9. Since the verdict is still out whether off-
targeting is a problem in general and specifically in Aspergilli, we here test two methods for 
reducing off-targeting. 
One of the exciting feats done with CRISPR-Cas9 in both S. cerevisiae and CHO cells is the ability 
to perform various genetic modifications without the need for integration of a selection marker and 
several modifications at a time [14–16]. In Aspergilli this ability would be extremely valuable, since 
available selection markers are often limited and markers such as pyrG, which can be recycled by 
direct repeat recombination [17,18], are even more limited. Each cycle of protoplastation, 
transformation, verification and marker recycling is time consuming, and if multiple modifications 
can be done at once, it will greatly accelerate the rate of which genetic engineering can be 
performed. To my knowledge, instances of doing multiple genetic modifications at once, outside 
ingration of multiple copies inserted by NHEJ, without the use of genome editing technologies, 
have not been published. An especially interesting use for genetic modifications without an 
accompanying selection marker is for the introduction of point mutations and other very small 
modifications, such as introduction of small tags etc. The ability to introduce specific point 
mutations are very powerful, for purposes such as protein engineering, metabolic engineering, 
studies in protein function etc., however it is also one of the most difficult types of genetic changes 
to introduce, since unlike gene deletions or insertions, it should preferably to be scar-less except for 
the desired change. While in some cases, co-insertion of an adjacent marker gene has to be 
accepted, this risks introducing positional effects on transcription levels of the gene of interest. In 
yeast several methods have been developed for seamless and markerless introduction of point 
mutations, such as perfetto delitto [19] or the 50:50 [20]. Both methods takes advantage of the fact 
the S. cerevisiae can integrate DNA with high frequencies of HR, even with very short flanks of 
homology, like 40-50 bp [21] which is short enough to include in a primer tail. Both methods are 
based on using a counter-selectable marker. While the counter-selectable markers are available in 
many fungal species, the requirement for flank length for homologous recombination is much 
higher, typically around 500-1000 even if non-homologous end-joining is impaired [22]. In fungal 
systems where counter-selectable markers are available point mutations can be introduced 
seamlessly [23], though the process is time-consuming, requiring complex vector constructions. In 
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filamentous fungi where counter-selectable markers are not available, it is a lot more complicated 
and usually leaves a selection marker [24]. However, with the recent adaptation of CRISPR-Cas9 
for use in filamentous fungi, it should be possible to enhance the processes for doing many types of 
genetic engineering. In this study we demonstrate how CRISPR-Cas9 can be used in Aspergillus 
nidulans to do various genetic modification without the introduction of a selection marker and also 
how single-stranded DNA (ssDNA) oligos can be used as a repair template for HR, as an alternative 
to conventional gene targeting substrates. 
 
Results 
Testing different promoters for the ability to express gRNAs 
Besides the ribozyme based method for expression of the gRNA presented in chapter three, several 
other methods were also tested. One method tested was just to express the gRNA from a 
conventional RNA polymerase II promoter, such as those used for protein expression. The gRNA 
with a protospacer targeting the yA [3] was inserted directly  into the A. nidulans gpdA promoter 
and the trpC terminator and inserted into the pFC331 vector, containing Cas9 expressed from the A. 
nidulans tef1 promoter, an argB marker gene and the AMA1 element.  
In both plants and mammalian systems, a common way to express the gRNA is from the U6 
promoter, which is transcribed by the RNA polymerase III, and thus avoids polyadenylation and 
export from the nucleus. The AspGD database [25] was searched for U6 small nuclear RNA, and 
three hits came up, annotated as U6-1, U6-2 and U6-3 in Aspergillus fumigatus. For promoter and 
terminator respectively, 307 bp upstream and 53 downstream of the U6-1 were used to express the 
gRNA with the yA protospacer. This construct was cloned into pFC331. 
Similar to the U6 promoter, the U3 promoter has been successfully used in some plants to express 
sgRNAs [26]. Using AspGD a single U3 snoRNA was found, from A. fumigatus. 486 bp upstream 
of the U3 snoRNA was used as promoter combined with the yA specific sgRNA and the SUP4 
terminator and the construct was inserted into pFC331. 
Another alternative used in Saccharomyces cerevisiae is the SNR52 promoter, since the yeast U6 
promoter, unlike that of the U6 in vertebrae is dependent on downstream elements as well as 
upstream elements [27] which limits its use for heterologous expression. To test if the SNR52 
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promoter could be used to express gRNAs in Aspergilli, a construct consisting of the S. cerevisiae 
SNR52 promoter, the sgRNA with the yA protospacer and the S. cerevisiae SUP4 terminator was 
cloned into pFC331 
 
 
Figure 4.1 Test of suitable promoter for sgRNA expression. All the transformants are based on NID5, all the vectors are 
based on pFC331 and the sgRNA is the same, the only difference is the promoter and terminator used for sgRNA 
expression. A) A. nidulans gpdA promoter and trpC terminator. B) S. cerevisiae SNR52 promoter and SUP4 terminator. 
C) A. fumigatus U6-1 promoter and terminator. D) A. fumigatus U3 promoter and S. cerevisiae SUP4 terminator. E) A. 
nidulans gpdA promoter and trpC terminator, but with the yA specific sgRNA flanked by a hammerhead and a HDV 
ribozyme. 
 
The different vectors were all transformed into NID5, which is NHEJ profient, but is auxotrophic 
for argine, uridine and uracil, and the results are summarized into Table 1. For comparison a 
transformation with pFC334 [3], which contains the same yA protospacer, and the gpdA promoter 
and trpC terminator, but with the sgRNA flanked by ribozymes, was included. The plates can be 
seen in Figure 4.1, panel A-E show sgRNA expression from the A. nidulans gpdA promoter the 
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yeast SNR52 promoter, the A. fumigatus U6-1 promoter, the A. fumigatus U3 promoter and the A. 
nidulans gpdA promoter but flanked with two ribozymes[3], respectively. 
Table 4.1 Test of different promoters for sgRNA expression, measured in their ability to 
induce mutagenesis in the yA gene leading to yellow-spored colonies 
Promoter Yellow or partial yellow /Green (frequency) 
PgpdA 0/95 (0%) 
PSNR52 0/55 (0%) 
PU6-1  0/64 (0%) 
PU3  0/57 (0%) 
PgpdA (ribozymes) 15/54 (22%) 
 
Testing strategies for limiting off-targeting 
One of the main concerns for using the CRISPR-Cas9 is the risk of off-targeting effects, in the form 
of unintended DSB (double strand breaks) in other places of the genome besides the targeted site. 
One strategy for limiting off-targeting is shortening the protospacer, since with a shorter 
protospacer, the requirements for specificity are higher for getting sufficient binding between 
gRNA and chromosomal DNA [10]. A construct was designed containing the same protospacer as 
pFC334, except shortened with 3 bp in the PAM distal end, for a total of 17 bp and cloned into 
pFC330 containing the pyrG selection marker, Cas9 and the AMA1 element. The resulting vector 
pCRISPR1-14p was transformed into NID5 and the resulting colonies displayed two distinct 
phenotypes, as seen in Figure 4.2, panel A and B. One was small and sporeless, the other type had 
no spores either, but an aberrant morphology with the texture of the colony raised. No spore color 
was discernable in either type. Sequencing of the region showed that the sequence was correct.  
Therefore, while shortening protospacers may be a viable strategy in human cells, it does not seem 
to be so in Aspergillus nidulans. 
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Figure 4.2 Test of shortened protospacer. A) and B) both shows transformation plates of NID5 transformed with a 
vector with a sgRNA in which the protospacer is only 17 bp rather than 20, but otherwise the same as the one in 
pFC334. 
Another method used to limit off-targeting is to disable one of the domains in the Cas9 protein, 
since two domains are both responsible for cutting one strand of the targeted DNA, thus by 
disabling one of them, the protein gets turned into a targeted nickase instead. Combined with two 
sgRNAs to make two nicks in close proximity on opposite DNA strands, this strategy has been 
successfully used to limit off-targeting in both plants and mammalian cell lines [5,28]. Four vectors 
were constructed, pCas9-D10A-argB, pCas9-H840A-argB, pCas9-D10A-pyrG and pCas9-H840A-
pyrG, similar to pFC330 and pFC331 except that the Cas9 carries either a D10A or H840A 
mutation, disrupting one of the cleaving domains, turning it into a nickase. Next two sets of 
protospacers were designed to make two nicks at opposite strands with a distance of either 16 bp or 
65 bp. The protospacers were expressed from the H3-H4 bidirectional histone promoter, instead of 
the gpdA promoter which has been used so far and cloned into the argB containing markers. The 
four resulting plasmids, two different mutations and two different protospacer configurations, all 
with the argB selection marker, were transformed into NID5. Due to low pH in the transformation 
media, some of the spores looked quite yellow, but a different kind of yellow than expected from a 
yA disruption, as seen in Figure 4.3 panel A-D. Four of the most intensely yellow looking colonies 
from each plate were re-streaked to MM-uri/ura, however all of them turned out to be green. Next 
the two vectors with the D10A nickase and either protospacer configuration inserted, was co-
transformed with the yA deletion vector [3], p6f-yA, linearized or circular in NID5, selecting for 
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pyrG. Figure 3, panel E and F show transformation plates with the vector having 16 bp overhang 
with linear and circular p6f-yA, respectively. Figure 4.3, panel G and H show transformation plates 
with the vector having 65 bp overhang with linear and circular p6f-yA, respectively. All cases 
results in the two types of colonies, a small and sporeless one, and normal looking ones. In general 
there was very few normal ones, but of among those, yellow spores was the most common type, 
indicating the yA deletion had been successful. Furthermore the most normal colonies resulted from 
transformation in which a circular gene targeting substrate and short overhangs of 16 bp were used, 
suggesting that using a circular substrate and relatively short overhangs are prefered. 
 
Figure 4.3 Test of Cas9 nickases. The nickase vectors contains either a D10A or an H840A mutation and two 
protospacer creating overhangs of either 16bp or 65 bp. A)-D) are transformed with a nickase vector alone, while E) 
and G) are co-transformed with a linear vector p6f-yA for deletion of yA, while F) and H) are co-transformed with 
circular p6f-yA. A) D10A, 16 bp. B) D10A, 65 bp. C) H840A, 16 bp. D) H840A, 65 bp. E) and F) D10A, 16 bp. G) and H) 
D10A and 65 bp. 
 
Investigating the effect of inducing a double strand break in an NHEJ deficient 
strain. 
So far, one of the main applications of the CRISPR-Cas9 technology in filamentous fungi has been 
to use it to boost gene targeting frequencies in a NHEJ proficient background. However, it is 
common to use NHEJ deficient strains for genetic engineering purposes and it would be useful to 
know how such a strain interacts with the DSB inducing properties of CRISPR-Cas9. The strain 
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NID1, identical to NID5 except it also contains an nkuA deletion, was transformed with pFC334. 
Two transformation plates can be seen in Figure 4.4, panel A and B. Out of approximately 88 
colonies not a single one displayed a yellow phenotype. While it is difficult to compare total 
number of colonies with the similar transformations in NID5, due to batch variation in protoplasts, 
the general tendency was that NID1 yielded fewer colonies than NID5. Considering that there are 
no template available, except for certain stages of the cell cycle, repair by HR is unlikely. With 
nkuA deleted, NHEJ is not available and repair by MMEJ would result in errors and as such result 
in the yellow phenotype. A likely scenario is that those colonies which in a NHEJ proficient strain 
would turn yellow due to faulty repair by NHEJ, dies in an NHEJ deficient background. However 
due to the multicellular nature some nuclei escapes Cas9, resulting in the green colonies observed. 
 
Figure 4.4 Using CRISPR-Cas9 in an NHEJ deficient background. A) and B) both shows transformation plates of NID1 
transformed with pFC334 
 
Expanding CRISPR-Cas9 applications to avoid integration of selection marker 
In Chapter 3 CRISPR-Cas9 was used to assist integration by homologous recombination in which a 
gene targeting substrate including a selection marker was integrated into the genome. In this case, 
selection for the vector carrying Cas9 and the sgRNA was not necessary. However if this scenario 
could be flipped so selection for the repair template could be avoided, it would be extremely 
beneficial, since it would allow for seamless integrations, deletions and point mutations, avoiding 
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potential positional effects from a neighboring marker gene and it would also allow for 
multiplexing, which is otherwise limited by the availability of selection markers.  To test this I 
transformed NID5 with pFC334 and, either a linearized or a circular yA deletion vector, p6f-yA, but 
selecting for argB instead of pyrG. Most of the colony mass was green, but many contained flecks 
of yellow. Unlike when selecting for a marker gene to be integrated, the rate of yellow spores, 
suggesting an integration event, was significantly lower , as seen on Figure 4.5, panel A and B, 
which used a linear and a circular repair template respectively. 
When not selecting for the DNA to be integrated, there is the possibility that a DSB happens but no 
template is available and therefore the break is repaired NHEJ, faulty or not. As such, it seems 
reasonable that disabling NHEJ, as it is done for improving classical gene targeting, would also 
enhance integration frequencies in this scenario. Especially considering that NID1 transformed with 
pFC334 did not yield a single yellow colony. To test if this was the case, the experiment was 
repeated in NID1, and transformation plates can be seen in Figure 4.5, panel C and D. To assess 
whether the yellow phenotype indeed was a result of the deletion template being integrated and not 
just mutagenesis by faulty NHEJ, 10 colonies from each setup, NID1 or NID5, linear or circular 
substrate, was stabbed to a MM plate containing arginine but neither uridine or uracil. For NID5 
transformed with a linear gene targeting substrate, 7 out of 10 grew. For NID5 transformed with 
circular gene targeting substrate 9 out of 10, while for NID1 transformed with either kind of 
substrate 10 out of 10 grew, confirming integration of the substrate. From the plates it can be seen 
that the tendency is that using a circular substrate seem more efficient that a linear substrate. Even 
greater impact however, is the effect of disabling NHEJ. 
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Figure 4.5  Inverting selection by using CRISPR-Cas9. Co-transformation of pFC334 and p6f-yA, selecting for pFC334 on 
MM-uri-ura plates. A) NID5, linear gene targeting substrate. B) NID5, circular gene targeting substrate. C) NID1, linear 
gene targeting substrate. D) NID1, circular gene targeting substrate. 
 
Using CRISPR-cas9 to introduce seamless point mutations. 
Another application which would be extremely useful, is if CRISPR-Cas9 can be used to introduce 
point mutations, here very loosely defined as small localized changes in a small numbers of bases, 
since compared to making insertions or deletion, making point mutations is a bit more tricky. 
Especially if no counter-selectable marker is available, it is often necessary to leave behind a 
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selection marker close to the gene being point mutated, which can possible affect expression levels 
by proximal effects. In any case, introducing point mutations tend to be more time consuming than 
insertions or deletions, typically requiring either additional cloning steps or transformation steps. 
An interesting aspect is that since the desired change is so small, it is possible that a ssDNA oligo 
could potentially be used as repair template, greatly speeding up the process, saving time spent 
constructing traditional gene targeting vectors. This strategy has been applied to genome 
engineering both with zinc-finger nucleases and CRISPR-Cas9 [29,30]. 
One thing to consider is that while a gene can be disrupted in many different ways, repairing a 
disabled gene requires much more precision. To be usable, for instance for protein engineering, 
precision is crucial. In chapter three, two of the strains created by mutagenesis by NHEJ, NID1829 
and NID1830 contain the same 2 bp deletion in yA, causing a frameshift leading to the yellow-
spored phenotype. To get an assay, which can be used to accurately, measure correct repair, it was 
decided to use this specific mutation and try to repair this 2 bp deletion, since frameshifts are much 
harder to spontaneously revert than base substitutions. 
A protospacer was designed to target the mutated allele but not the wildtype of yA, and the 
expression cassette cloned into pFC330, giving the vector pCRISPR1-13p. Two oligos of 60 
nucleotide (nt) (CSN520) and 90 nt (CSN518) were designed to correspond to the wildtype yA 
allele, flanking 30 and 45 nt on each side of the mutation site. Furthermore, three vectors were 
created containing parts of the wildtype yA, with flanks, centered from the mutation site of 500 bp, 
1000 bp and 2000 bp respectively, named p1-yA500, p1-yA1000 and p1-yA2000 respectively. One 
thing to notice is that the vector p1-yA2000, due to the relatively short length of yA, 2147 bp 
including introns, as a consequence contains the entire gene and approximately 1300bp up and 
approximately 500 bp downstream sequence, as such it is possible it is still functional if integrated 
ectopically. 
The strain NID1829 was protoplasted and co-transformed with pCRISPR1-13p and either one of the 
two ssDNA oligos or one of the three vectors, all designed to provide a template for repair of the 2 
bp deletion in yA. The transformations plate can be seen in Figure 4.6. Panel A and B shows the use 
of oligo templates, CSN520 and CSN518 of 60 and 90 bp length respectively. Panel C, D and E 
shows circular p1-yA500, p1-yA1000 or p1-yA2000 used for repair template. 
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Figure 4.6 Repair of yA in an NHEJ proficient background. NID1829 transformed with pCRISPR1-13p, targeting the yA 
mutant allele and different gene targeting substrate for repair of yA. A) and B) are using ss oligos of either 60 or 90 
nucleotides in length respectively. C), D) and E) are using circular vector encoding parts of the yA gene, with flanks 
from each side of the mutation being either 500, 1000 or 2000 bp respectively. 
 
A single green colony from the transformation with the 90 nt oligo, showed that using oligos as a 
repair template for HR is possible, although the rate of correct repair is very low. Similarly, the 
circular substrate p1-yA2000 gave rise to a few green colonies, however the conclusion is less clear, 
since ectopic integration, possible in a NHEJ proficient background, can lead to heterologous 
expression due the long flank length. However, there is no selection pressure to integrate the 
fragment. 
Since it showed that the oligo was a valid repair template, two 90 nt ssDNA oligos was designed, to 
either introduce a stop codon (CSN486) or the same 2bp deletion as the one in NID1829 (CSN519). 
NID1 was co-transformed with pFC334 and either of the two oligos. Transformation plates can be 
seen in Figure 4.7, panel A showing transformation with an oligo introducing a stopcodon and the 
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panel B showing transformation with an oligo encoding the 2 nt deletion corresponding to the one 
in NID1829. 
 
Figure 4.7 Introducing a specific point mutation using oligos in and NHEJ deficient background. NID1 transformed with 
pFC334 and a 90 nt oligo designed to introduce either A) a stop codon in yA or B) the same 2 bp deletion as found in 
NID1829. 
 
The transformations resulted in approximate 40% yellow colonies, however both green and yellow 
colonies were even more uneven in appearances than normally seen when transforming with AMA1 
based plasmids. Five colonies from the transformation with the 2 bp deletion oligo, CSN519, were 
sequenced in the region containing the expected mutation. Three of the five had the correct 2 bp 
deletion as expected from the oligo, while the two others, while mutated in the locus, had a different 
deletions. This shows, that not surprisingly, this strategy is much more efficient in a NHEJ deficient 
background, but also that in lieu of mutagenesis by faulty NHEJ, which is not possible in a NHEJ 
deficient recipient, oligo-directed mutagenesis can be used as a substitute.  
Next, one of the strains carrying the 2 bp deletion, NID2028 was protoplasted and co-transformed 
with pCRISPR1-13p and either of the two oligos, CSN518 or CSN520, or one of the three vectors 
p1-yA500, p1-yA1000 or p1-yA2000, either linearized or in circular form. The transformation 
plates can be seen in Figure 4.8. Panel A and B shows CSN520 and CSN518, panel C, D and E 
shows linearized p1-yA500, p1-yA1000 or p1-yA2000 as template and panel F, G and H shows 
circular p1-yA500, p1-yA1000 or p1-yA2000 used for repair template. 
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Figure 4.8 Repair of yA in a NHEJ deficient background. NID2028, which is NHEJ deficient but otherwise identical to 
NID1829, transformed with pCRISPR1-13p, targeting the yA mutant allele and different gene targeting substrate for 
repair of yA. A) and B) are using ss oligos of either 60 or 90 nucleotides in length respectively. C), D) and E) are using 
linearized vector encoding parts of the yA gene, with flanks from each side of the mutation being either 500, 1000 or 
2000 bp respectively. F), G) and H) are using circular vector encoding parts of the yA gene, with flanks from each side 
of the mutation being either 500, 1000 or 2000 bp respectively.  
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Considering the relatively high rate of integration of the yA deletion vector p6f-yA and also correct 
introduction of the 2 bp deletion with the CSN519 oligo, the low frequency of repair of yA is 
somewhat surprising.  
There are several parameters to consider when designing gRNAs, and a great variety of online tools 
exist. In organisms with large genomes, e.g. plants and animals, often the main concern is limiting 
off-targeting by finding the most unique sites for targeting within the gene of interest. Other studies 
have focused on optimizing on-target efficiency [31,32], finding the parameters leading to the most 
efficient gRNAs. However, when using CRISPR-Cas9 for introducing point mutations, the choice 
of gRNA is often quite limited since it needs to target the gene of interest but not the template used 
for introducing the point mutation. In this case only two protospacers are available without 
introducing silent mutations in the repair template. The other possible protospacer was designed and 
cloned into pFC330, creating the vector pCRISPR1-20p. The experiments were repeated with the 
new vector, however the frequency of repair did not change significantly.  
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Figure 4.9 Repair of yA in a NHEJ deficient background. NID2028 is transformed with pCRISPR1-20p, targeting the 
same yA mutant allele as pCRISPR1-13p, but with a different protospacer and different gene targeting substrate for 
repair of yA. A) and B) are using ss oligos of either 60 or 90 nucleotides in length respectively. C), D) and E) are using 
linearized vector encoding parts of the yA gene, with flanks from each side of the mutation being either 500, 1000 or 
2000 bp respectively. F), G) and H) are using circular vector encoding parts of the yA gene, with flanks from each side 
of the mutation being either 500, 1000 or 2000 bp respectively. 
Overall, these results show that introducing small changes such deletions, insertions or substitutions 
are possible with both long ssDNA oligos (90nt), but also linearized or circular vectors. However 
due to the low frequency in the yA repair assay and the high colony density on the plates, it is not 
possible to say anything specific on the frequencies. However the tendencies seem to be similar to 
what is observed when using the yA deletion vector, that a circular substrate works better than linear 
85 
 
substrate[3], and also longer flanks seem to be more efficient than shorter flanks [22]. It seems that 
repairing yA was much more inefficient compared to mutating it, even considering that not every 
yellow colony had the specific desired mutation, although again there is not enough data for 
anything conclusive. However there is no doubt that it is going to be an extremely useful technique, 
especially if further studies reaffirms that ssDNA oligos can be used with high gene targeting 
frequencies, greatly speeding up the process. 
 
Discussion 
Currently six papers on using CRISPR-Cas9 for genome editing in filamentous fungi, including the 
one presented in chapter 3, have been published. What is really interesting is that the main 
challenge, introducing the components of the system, particularly the gRNA, was solved in widely 
different manners. In Trichoderma reesei, in a work by Liu and co-workers [1], a codon-optimized 
Cas9 was randomly integrated using either a constitutive or an inducible promoter and the gRNA 
made by in vitro transcription and introduced into protoplasts. In Pyricularia oryzae (Magnaporthe 
oryzae), in a study by Arazoe and co-workers [2] again a codon-optimized Cas9 was used, but this 
time inserted in a non-integrative, transiently expressed vector together with the constructs 
necessary for expression of the gRNA which is done either from a P. oryzae U6-1 or U6-2 RNA 
polymerase III promoter or the RNA polymerase II promoter trpC. In Neurospora crassa by Matsu-
ura and co-workers [4], transient plasmid expression was similarly used, however for expression of 
the gRNA, the S. cerevisiae SNR52 promoter was used. In Aspergillus fumigatus by Fuller and 
coworkers [33] the humanized Cas9, under control of the S. cerevisiae TEF1 promoter  and the 
gRNA under control of the S. cerevisiae SNR52 promoter [34] was integrated into the genome by 
random integration, in either one or two steps. In Ustilago maydis by Schuster and co-worker [35] 
expression from transient plasmids was also used, and an U. maydis U6 promoter was used for 
sgRNA expression. Comparing these systems show huge differences in what works and what does 
not work. In T. reesei codon-optimization was found to be necessary [1], while the humanized Cas9 
worked in A. fumigatus [33]. Likewise, while strategies for expressing the gRNA, including 
expressing from RNA polymerase II promoters directly, fungal U6 promoters or the S. cerevisiae 
SNR52 promoter proved unsuccessful in A. nidulans as described in this study, while successful in 
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other organisms. Overall this leaves room for lots of optimizations, figuring out what works and 
what does not work, and why.  
Another interesting concern is the delivery of Cas9 and the sgRNA. Of the two components, Cas9 
and the sgRNA, Cas9 is the same every time, while the sgRNA changes with every target, greatly 
affecting the strategies used for expressing them. For expression of the Cas9 protein, that has been 
used in filamentous fungi so far, is either genomic integration or transient expression from 
plasmids. Considering stability, genomic integration is by far the most stable way of expression, 
since once a pure strain is obtained, then one copy of the Cas9 gene will be present in every single 
nuclei. The disadvantage however that it will be constitutively present, and while no negative 
impact as a result of Cas9 expression, has been observed in filamentous fungi so far, in S. cerevisiae 
reduced growth rates have been observed as a result of strong Cas9 expression [36]. A way to 
circumvent this is by using inducible promoters for Cas9 expression, such as done in T. reesei [1]. 
Alternatively, with transient expression, which so far in all cases have been DNA based, the DNA 
carrying the various elements is lost again, leaving a cleaner strain. However expression is probably 
uneven and there is the risk that the DNA will integrate into the genome. Along the same lines of 
thought, so far all the systems have been dependent on selection, since when doing transformation 
only a subset of cells are actually competent. That leaves three options, a selectable phenotype, the 
DNA vehicle for expression one or both of the component or the gene targeting template in the 
cases of HR. The most flexible of these is the DNA vehicle, but again it might increase the risk of 
genomic integration. And again it shows that there are lots of parameter to consider. 
For the purpose of making insertions, deletions and point mutations without the integration of a 
selection marker, several types of gene targeting substrates have been tested. If looking purely at 
optimizing the frequency of correct integrations, the tendency was that circular substrates with long 
flanks did seem to be the most efficient. However when designing an optimal strategy for genetic 
engineering, the gene targeting frequency is only one parameter. Different gene targeting substrates 
have different advantages. While the most efficient, circular gene targeting substrates tends to be 
the most time consuming to make, requiring a cloning step. However if the gene targeting substrate 
is complex, consisting of many different parts, it might be the only way to go. Linear substrates can, 
if simple, be made by fusion PCR, speeding up the process, while more complex ones are easiest 
made by cloning a vector and subsequent linearization, e.g. by restriction enzymes. ssDNA oligos 
can be made synthetically, and are commercially available. While limited by their small size, they 
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can easily incorporate a point mutation or a short tag or even more interestingly is the option of 
incorporation of randomized nucleotides, for instance to vary a single amino acid at a specific 
position in a protein. However the tradeoff seem to be lower gene targeting efficiency, compared to 
a longer double-stranded gene targeting substrate. Even greater effect is the presence or absence of 
NHEJ. While no attempts on multiplexing have been done during these studies, the foundation have 
been laid with the exploration of gene targeting without an accompanying selection marker. 
However, it is reasonable to assume that the differences in gene targeting efficiencies will only be 
exacerbated, as the number of targets go up. Therefore, one of the most important parameters when 
deciding on a genetic engineering strategy is the screening system available. With high-throughput 
methods available or with a phenotype to screen for, compromises to gene targeting efficiency can 
be made. However the less efficient the screening method is, the more crucial it is to have high gene 
targeting frequencies, so that correct transformants can be identified in a timely manner. 
Another aspect of interest is off-targeting, especially since the verdict is still out to whether it is a 
problem or not. Here two methods for limiting off-targeting were tested. One was based on 
shortening the protospacer from 20 bp down to 17, which has been shown to be a viable strategy in 
human cells [10]. However this lead to aberrant, sporeless colonies in A. nidulans. While 
protospacers of 18 or 19 bases have not been tested, using 17 bp is certainly not an effective 
strategy, despite it being an otherwise simple and elegant solution if it did work as in human cells. 
The other method is based on creating two nicks in close proximity, rather than a single DSB. When 
used to facilitate integration of a gene targeting substrate by HR, two subpopulations of colonies 
arose. One was tiny and sporeless, while the other appeared normal in morphology and showed a 
similar yellow/green distribution as that observed when stimulating gene targeting with wildtype 
Cas9. While the small colonies is a bit worrisome, further analysis should be able to shed light upon 
whether any negative effects is confined to those, in which case it is not a problem since they are 
easily separated, or if the normal colonies also are somehow affected. If further analysis reveals no 
issues with normal sized colonies, it is good a strategy to minimize off-targeting, when doing gene 
targeting. It has two disadvantages compared to wildtype Cas9, however. The nickase variant, 
unlike the wildtype does not seem to induce mutagenesis by NHEJ if no template is available, 
somewhat limiting the applications, although not greatly so, since applications available for gene 
targeting by HR are more versatile. The other disadvantage is that because the need for expressing 
two sgRNAs rather than one, the cost and complexity of creating the vectors goes up. However 
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further studies will have to be done to figure out the degree of which off-targeting is a concern in 
Aspergillus species. 
Overall this study explores some more aspects of using CRISPR-Cas9 for genetic engineering in 
Aspergillus, and especially the prospect of not having to integrate a selection marker as a part of the 
gene targeting substrate and be able to use ssDNA oligos as a repair template is exciting. 
 
Materials and methods 
Strains and media 
Escherichia coli strain DH5α was used to propagate all plasmids. The Aspergillus nidulans strains 
used in this study are listed in Table 1. Genomic DNA (gDNA) from fungal strains was isolated via 
FastDNA SPIN Kit for Soil DNA extraction kit (MP Biomedicals, USA). All strains were 
cultivated on standard glucose based minimal medium (MM) (1% glucose, 1x nitrate salt solution 
[37], 0.001% Thiamine, 1x trace metal solution [38], 2% agar), supplemented with 10mM uridine 
(Uri), 10mM uracil (Ura), and/or 4mM L-arginine (Arg) when required. Solid plates containing 5-
fluoroorotic acid (5-FOA) were made as MM+Arg+Uri+Ura supplemented with filter-sterilized 5-
FOA (Sigma-Aldrich) to a final concentration of 1.3 mg/ml. For transformation media (TM) 
glucose was replaced with 1M sucrose. 
Table 4.2 Strains used in the study 
NID1 argB2, veA1, pyrG89, nkuAΔ 
NID5 argB2, veA1, pyrG89 
NID1829 argB2, veA1, pyrG89, yA* 
NID2028 argB2, veA1, pyrG89, nkuAΔ, yA* 
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PCR and USER cloning 
All vectors were constructed by PCR as described by Nødvig et al [3] and USER cloning as 
described by Hansen et al [39]. Detailed vector construction can be found in appendix 1 and the 
primers used in appendix 2. An overview of the vectors can be found in Table 3. 
 
Table 4.3 vectors used in the study 
Name Genotype Source 
pFC330 AMA1-pyrG-Cas9-PacI/Nt.BbvCI cassette [3] 
pFC331 AMA1-argB-Cas9 PacI/Nt.BbvCI cassette [3] 
pFC334 AMA1,argB, Cas9, PS1 [3] 
p6f-yA yA-up, Afl-pyrG, yA-dw [3] 
pCRISPR-gpdA-1a AMA1,argB, Cas9, PS1 (gpdA) This study 
pCRISPR-SNR52-1a AMA1,argB, Cas9, PS1 (SNR52) This study 
pCRISPR-U6-1-1a AMA1,argB, Cas9, PS1 (U6-1) This study 
pCRISPR-U3-1a AMA1,argB, Cas9, PS1 (U3) This study 
pCRISPR1-13p AMA1, pyrG, Cas9, PS13 This study 
pCRISPR1-20p AMA1, pyrG, Cas9, PS20 This study 
pCRISPR1-14p AMA1, pyrG, Cas9, PS14 This study 
pCas9-D10A-argB AMA1- argB -Cas9(D10A)-PacI/Nt.BbvCI cassette This study 
pCas9-H840A-argB AMA1- argB -Cas9(H840A)-PacI/Nt.BbvCI cassette This study 
pCas9-D10A-pyrG AMA1-pyrG-Cas9(D10A)-PacI/Nt.BbvCI cassette This study 
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pCas9-H840A-pyrG AMA1-pyrG-Cas9(H840A)-PacI/Nt.BbvCI cassette This study 
pCRISPRn1-10-11a AMA1- argB -Cas9(D10A), PS10-PS11 This study 
pCRISPRn1-11-12a AMA1- argB -Cas9(D10A), PS11-PS12 This study 
pCRISPRn2-10-11a AMA1- argB -Cas9(H840A), PS10-PS11 This study 
pCRISPRn2-11-12a AMA1- argB -Cas9(H840A), PS11-PS12 This study 
 
Table 4.4 Protospacers used in the study 
Protospacer Sequence Gene 
PS1 GGCGGAGTATCATAACATCG yA 
PS10 ATCAATAAGACTGCCTCAAT yA 
PS11 GCGACCCTACGCGGTTATAA yA 
PS12 GTATTTCTGCTAACTCTCTC yA 
PS13 TCGGCGGAGTATCATAATCG yA (mutated) 
PS14 GGAGTATCATAACATCG yA  
PS20 ATCATAATCGAGGTTGAGTC yA (mutated) 
 
Transformation and strain validation by Tissue-PCR 
Protoplastation was performed as described by Nielsen et al [23]. Transformation using either pyrG 
or argB as genetic marker was performed as described by Nødvig et al [3]. One note, in the case of 
inverted selection, approximately 1 µg of CRISPR-Cas9 vector and approximately 3 µg gene 
targeting substrate were used. 
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Appendix 4.1 Vector construction 
 
Vectors for testing different promoter for sgRNA expression 
A gBlock encoding the same yA specific sgRNA as pFC334, protospacer 1, with the gpdA promoter 
and trpC terminator was ordered from IDT (IDTdna, Belgium), PCR amplified with the primers 
CSN389+CSN390 and cloned into pFC331 yielding the vector pCRISPR1-gpdA-1a. 
Another gBlock encoding the same yA specific sgRNA but this time with the S. cerevisiae SNR52 
promoter and SUP4 terminator was likewise amplified with primer CSN389+CSN390, cloned into 
pFC331, yielding the vector pCRISPR-SNR52-1a. 
A third gBlock with the same yA specific sgRNA, but flanked with 307 bp upstream and 53 bp 
downstream of the A. fumigatus U6-1 snRNA, to constitute the U6-1 promoter and terminator, was 
amplified with primer CSN389+CSN390 and cloned into pFC331, yielding the vector pCRISPR-
U6-1-1a.  
The vector pCRISPR-U3-1a was made by amplifying the 486 bp upstream of the U3 snoRNA of A. 
fumigatus from A. fumigatus gDNA with primers CSN438+CSN439, while the yA sgRNA and the 
SUP4 terminator was amplified with primers CSN363+CSN390 using pCRISPR-SNR52-1a as 
template. Fragments were cloned into pFC331 by USER cloning, giving the vector pCRISPR-U3-
1a 
Cas9 nickase vectors 
Cas9 including the A. nidulans tef1 promoter and terminator was amplified in two part introducing 
either the D10A or the H840 mutation with the primer tails. For the D10A mutation upstream part 
of Cas9 was amplified with primers CSN385+CSN351 and downstream with primers 
CSN352+CSN323. Similarily the H840A was introduced by amplifying 5’ end with primer 
CSN385+CSN353 and 3’end with primers CSN354+CSN323, all four fragments using pU0000-
Cas9 as template [1]. Additionally a fragment containing either the argB or pyrG fungal selection 
marker and part of the ampicillin bacterial selection marker was amplified from CSN381+CSN380 
or CSN382+CSN380 with pAC76 or pAC161 (Aspergillus plasmid collection) and two fragments 
containing the remaining part of the ampicillin marker gene and the 5’ end of  the AMA1 element 
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and one containing the 3’ end of AMA1 was amplified with primer CSN379+KBR087 and 
KBR088+CSN386 using pAC76 as template. From this four vectors were assembled by USER 
fusion, pCas9-D10A-argB, pCas9-H840A-argB pCas9-D10A-pyrG, pCas9-H840A-pyrG, each 
containing either argB or pyrG and either the D10A or H840A mutation. 
Three protospacers for targeting yA, protospacer 10, 11 and 12 were designed, in such way that the 
combination PS10+11 yields two nicks 16 nucleotides apart on opposites strands, while PS11+12 
yields two nicks on opposite strand 65 nucleotides apart. For expression of the sgRNAs the A. 
nidulans Histone 3 and 4  bidirectional promoter was used. The promoter fragment for the PS10+11 
pair was amplified with primers CSN497+CSN498, while the promoter for the PS11+12 pair was 
amplified with primer CNS499+CSN498. The trpC terminator with the gRNA backbone and a 
HDV ribozyme is amplified using pFC334 as template with primers CSN503+CSN500 for PS10, 
CSN501+CSN504 for PS11 and CSN502+CSN503. These fragments was assembled in a total of 
four vectors with a promoter and two terminator fragments in each, in such way that all the vectors 
have either the PS10+11 or the PS11+12 combination of gRNAs and either the D10A or H840A 
mutation and all of them the argB selection marker, yielding the vectors pCRISPRn1-10-11a, 
pCRISPRn1-11-12a, pCRISPRn2-10-11a and pCRISPRn2-11-12a. 
CRISPR-Cas9 vectors pFC330, pFC331, pFC334 and yA deletion vector p6f-yA were constructed 
as described in chapter three [1] 
 
Vector with alternative sgRNAs, pCRISPR1-13p, pCRISPR1-14p and pCRISPR1-20p  
For each vector two PCR fragments were made using pFC334 as template and the fragments were 
cloned into vector pFC330. Vector pCRISPR1-13p was made with primers CSN389+CSN521 and 
CSN522+CSN390. Similarly vector pCRISPR1-14p was made with primers CSN389+CSN536 and 
CSN537+CSN390. And vector pCRISPR1-20p was made with primers CSN389+CSN574 and 
CSN575+CSN390. 
Single stranded oligos for repair templates are primers CSN518 and CSN520 . The double stranded 
vector was made by amplifying parts of yA from A. nidulans genomic DNA, using primer 
CSN568+569 for the 500 bp flanks, CSN570+571 for 1000 bp flanks and CSN572+573 for 2000 bp 
flanks. These three fragments were separately cloned into vector pU0002[2] by USER cloning. 
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Appendix 4.2 Primer table 
Promoter comparison 
CSN389 PgpdA-pac-
up-fwd 
GGGTTTAAU GCGTAAGCTCCCTAATTGGC 
CSN390 TtrpC-short-
pac-dw-rv 
GGTCTTAAU GAGCCAAGAGCGGATTCCTC 
CSN363 yA-crispr-
planD-fwd 
AGTATCAU AACATCG 
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG 
CSN438 Afum-U3p-
fwd 
GGGTTTAAU GATCACATAGATGCTCGGTTGACA 
CSN439 Afum-U3p-
PS1-rv 
aTGATACUCCGCC GCTGTTAGCAAAATGTTCTGACTTG 
Nickase Cas9 vectors 
CSN323 Anid-Ttef1-
L3-rv 
ATTACACTU GTATTGGGATGAATTTTGTATGCAC 
CSN378 PtrpC-L3-fwd AAGTGTAAU GCTAGTGGAGGTCAACACATCAATGC 
CSN379 ampR-int-fwd ACATGAUCCCCCATGTTGTGCAAAAAAG 
CSN380 ampR-int-rv ATCATGUAACTCGCCTTGATCGTTG 
CSN381 argB-L3-alt 
fwd 
AAGTGTAAU ACTAGGTAATATCGCGTGCATTCCG   
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CSN382 pyrG-L3-alt-
fwd 
AAGTGTAAU TCCTCGTGTACTGTGTAAGCGCCC 
CSN385 Anid-Ptef-Pac-
regen-fwd 
AGGGTTUAATTAAGACCTCAGC CGAGACAGCAGAATCACCGC 
CSN386 Ama-alt-out-
pac-regen-rv 
AAACCCUCAGC GGAAACAGCTATGACCATGAGATCTTCCCG  
KBRP0
87 
AMA1-int-rv ATTGGGGUACTAACATAGCCATCAAATGCC 
KBRP0
88 
AMA1-int-
fwd 
ACCCCAAUGGAAACGGTGAGAGTCCAGTG 
CSN351 Cas9-D10A-rv ATGGCCAGU CCGATGCTATACTTCTTGTCCAT 
CSN352 Cas9-D10A-
fwd 
ACTGGCCAU TGGAACGAACTCGGTTGGT 
CSN353 Cas9-H840A-
rv 
ATGGCGU CAACATCGTAGTCCGACAACCG 
CSN354 Cas9H840A-
fwd 
ACGCCAU CGTCCCGCAATCCTTCCTT 
Vectors with alternative sgRNAs 
CSN521 gRNA-PS13-
rv 
AGCTTACUCGTTTCGTCCTCACGGACTCATCAGTCGGCGCGGTGAT
GTCTGCTCAAGCG 
 
CSN522 gRNA-PS13-
fwd 
AGTAAGCUCGTC TCGGCGGAGTATCATAATCG 
GTTTTAGAGCTAGAAATAGCAAGTTAAA 
 
CSN522 gRNA-PS14-
fwd 
AGTAAGCUCGTCTCGGCGGAGTATCATAATCGGTTTTAGAGCTAG
AAATAGCAAGTTAAA 
 
CSN536 gRNA-PS14-
rv 
AGCTTACUCGTTTCGTCCTCACGGACTCATCAGGGAGTACGGTGA
TGTCTGCTCAAGCG 
CSN537 gRNA-PS14-
fwd 
AGTAAGCUCGTCGGAGTATCATAACATCGGTTTTAGAGCTAGAAA
TAGCAAGTTAAA 
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CSN574 gRNA-PS20-
rv 
AGCTTACUCGTTTCGTCCTCACGGACTCATCAG ATCATA  
CGGTGATGTCTGCTCAAGCG 
CSN575 gRNA-PS20-
fwd 
AGTAAGCUCGTC ATCATAATCGAGGTTGAGTC 
GTTTTAGAGCTAGAAATAGCAAGTTAAA 
yA repair templates 
CSN518 yA-repair-
90bp 
TTGCTACGGACTGGACATATCTTACTTCGGCGGAGTATCATAACAT
CGAGGTTGAGTCTGGCTATAACGTCTTGTAAGCTCGATTTTTCC 
CSN519 yA-2bp-del-
90bp 
CTTGCTACGGACTGGACATATCTTACTTCGGCGGAGTATCATAATC
GAGGTTGAGTCTGGCTATAACGTCTTGTAAGCTCGATTTTTCCT 
CSN520 yA-repair-60-
bp 
GACATATCTTACTTCGGCGGAGTATCATAACATCGAGGTTGAGTCT
GGCTATAACGTCTT 
CSN568 yA-rep-500-
fwd 
GGGTTTAAU TGTCATCAATAACCTTCCCTTCAA 
CSN569 yA-rep-500-rv GGTCTTAAU AACTGTCCGTCAACTTCATATACCC 
CSN570 yA-rep-1000-
fwd 
GGGTTTAAU GCAAATCCAGTAGGAAAATACGGT 
CSN571 yA-rep1000-rv GGTCTTAAU GTTTTCTGTCGTGAGGGCGTA 
CSN572 yA-rep-2000-
fwd 
GGGTTTAAU GCACCATCGACCGTTTGATAT 
CSN573 yA-rep-2000-
rv 
GGTCTTAAU GTCTCCGACGCAATCACCAT 
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Chapter 5: Conclusion and perspectives 
This thesis presents much of the research done during my PhD, for which the overarching theme 
has been to explore different ways in which DNA repair can be manipulated, to enhance gene 
targeting. 
In chapter two, I explored a method for making multiple transient gene disruptions, by the means of 
cre-lox recombination. This was achieved by inserting a dominant selection marker, flanked by 
loxP sites into an intron of a gene to be disrupted. While inserted the insert will prevent correct 
splicing and thus disable protein function, however once excised by cre-lox recombination only a 
single loxP scar is left and this is small enough to be tolerated in the intron. This was demonstrated 
to be a successful strategy for yA and pyrG. Unfortunately, whether it was likewise applicable for 
nkuA was not tested during this study. Nonetheless, there is reason to believe this will also work for 
nkuA, providing an alternative to transient inactivation by direct repeat recombination in which 
multiple genes can be inactivated simultaneously. 
In chapter three, the focus changed from finding a smarter way of transiently disabling NHEJ 
combined with other genes to circumvent the problem of having to disable NHEJ, to have high 
frequencies of gene targeting in the first place. The genome editing technology CRISPR-Cas9, 
originating from bacteria and archaea, but recently adapted to a wide range of eukaryotes, showed 
promises that it could similarly be of great use in filamentous fungi. A vector set was created, based 
on the AMA1 element, allowing for transient expression in a wide range of Aspergilli and also 
some species outside the genus, such as some Penicillium and Talaromyces species. A codon 
optimized Cas9, optimized to A. niger and tagged with an C-terminal SV40 nuclear localization 
signal and combined with the AMA1 element and one of four selection markers, pyrG, argB, hph or 
ble makes the core of each vector. The main challenge was finding a way to express the other 
component of the CRISPR-Cas9 system, the sgRNA. By flanking the sgRNA with ribozymes, it 
was possible to use RNA polymerase II promoter for expression of the sgRNA [1], while normally 
an RNA polymerase III promoter is necessary. With a functional CRISPR-Cas9 system in place, I 
demonstrated that it could be used to both introduce small indels in six different NHEJ proficient 
species by faulty NHEJ repair, but also that it could be used to greatly enhance frequencies of repair 
by homologous recombination, similar to that on an NHEJ deficient strain, if a donor DNA template 
was co-transformed. 
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In chapter four, three themes were explored, building upon the CRISPR-Cas9 platform presented in 
chapter three. First four alternative promoters were tested for their ability to be used for sgRNA 
expression. Unfortunately, none of them worked in A. nidulans. Interestingly for three of them, very 
similar strategies have been successfully used in other filamentous fungi. One important thing to 
notice with the ribozyme based expression strategy presented in chapter three, since it is based on 
RNA polymerase II promoters, is that it also allows for the use of inducible promoters, while RNA 
polymerase III promoters are usually coding for household genes and as such are constitutively 
expressed. Next two strategies for limiting off-targeting effects were tested. One was based on 
truncating the protospacer, instead of using 20 bp, 17 bp was used, however this shortened 
protospacer resulted in abnormal sporeless colonies, strongly suggesting that this is not an 
appropriate strategy to use in A. nidulans. Also tested was using paired nickases, using two 
sgRNAs, causing two nicks in proximity, rather than causing a single double strand break.  Results 
showed that while paired nickases are unsuitable to do mutagenesis, likely because the sticky ends 
are far more easily repaired in an error-free way than the blunt ends caused by wildtype Cas9. For 
repair by HR, however it showed promises. Two types of colonies resulted from transformations. A 
subpopulation showed a small and spore-less phenotype, and a more normal type of colony. While 
the number of “normal” colonies were low, the ratio between green and yellow colonies suggested 
it can be a viable strategy, if off-targeting ends up being a concern. The last area of investigation 
was whether CRISPR-Cas9 could be used to allow for insertions, deletions and point mutations 
without having to integrate aa accompanying selection marker. The main conclusions are that it is 
certainly possible, but that NHEJ deficiency greatly enhances correct integration, similar to how it 
enhances conventional gene targeting. Furthermore, I demonstrated that short single-stranded DNA 
oligos could be used as a repair templates, with varying amount of success. While there is still some 
optimizations to be done, the fact that various genetic modifications can be performed without the 
integration of a selection marker, is an important finding, since it is a prerequisite for multiplexing 
without being limited by the number of selection markers,. 
The adaptation of the CRISPR-Cas9 genome editing tool for the use in Aspergilli and other 
filamentous fungi brings many exciting prospects, besides those outlined in this thesis. CRISPR-
Cas9 is not the first genome editing technology, however what is separating it from its predecessors 
is the low barriers of entry. Meganucleases, while useful for some purposes are in general too 
specific to be useful for genome editing. Zinc-finger nucleases and to a lesser degree TALENs are 
expensive and time-consuming to develop, and for difficult to engineer organism, such as 
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mammalian cell systems, the effort to develop a ZFN or a TALEN to target a specific locus, might 
be worth it. Aspergilli however are significantly easier to engineer, while not as easy as some of the 
classical cell-factories such S. cerevisiae and E. coli, and so far the efforts have not really been 
worth it and thus explored, except for a recent paper describing the use of TALENs in P.oryzae [2]. 
However with CRISPR-Cas9, once a system is established, the cost per target is low enough, that 
even for organisms which are very genetically amendable, the technology has proven useful. 
Similarly, for Aspergilli it has the possibility to transform the conventional strategies for doing 
genetic manipulations. 
Of course, CRISPR-Cas9 is extremely interesting from the perspective of genome editing, having 
the potential to change the paradigms of how we perform genetic engineering. However, another 
interesting application is for use in gene regulation. By inactivating of both cleavage domains, the 
resulting protein, dCas9 is a programmable DNA binding protein, which can be fused to other 
domains, e.g. the synthetic VP64 [3] acting as transcriptional activator, or repressing domains. The 
filamentous fungi, including Aspergilli represents a huge reservoir of interesting secondary 
metabolites, however many clusters are silent under laboratory conditions, and as such synthetic 
transcriptional activators could be a valuable tool. While the focus of this thesis have been on the 
genome editing aspects of CRISPR-Cas9, it lays a solid foundation to build tools for use in gene 
regulation rather than gene editing. 
Finally, it is interesting to note that while the focus both in this thesis but also in general when it 
comes to this new generation of genome editing based on RNA-guided nucleases, has to a very high 
degree been on the S. pyogenes Cas9. Homologs of the S. pyogenes Cas9 have be identified, 
characterized, and utilized, but recently other proteins distinct from Cas9 have been investigated for 
their ability to be used for genome editing. One of such systems is Cpf1 nuclease from Francisella 
novicida [4], which produce sticky ends rather than the blunt ends produced by Cas9, which can be 
a useful complement tool to Cas9 based genome editing. However, considering how prevalent 
CRISPR systems for immune defense are in both bacteria and archaea, this is probably just the tip 
of the iceberg and more valuable additions to the genetic engineering toolbox could be out there. 
Ultimately, this thesis presents some important advances in the application of genome editing 
technologies in Aspergillus and tools that can help facilitate faster and better genetic engineering 
strategies. 
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